US20140296507A1 - Polymer Hydrogels and Methods of Preparation Thereof - Google Patents

Polymer Hydrogels and Methods of Preparation Thereof Download PDF

Info

Publication number
US20140296507A1
US20140296507A1 US14/150,430 US201414150430A US2014296507A1 US 20140296507 A1 US20140296507 A1 US 20140296507A1 US 201414150430 A US201414150430 A US 201414150430A US 2014296507 A1 US2014296507 A1 US 2014296507A1
Authority
US
United States
Prior art keywords
polymer
polymer hydrogel
cross
water
hydrogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/150,430
Inventor
Alessandro Sannino
Luigi Ambrosio
Luigi Nicolais
Christian Demitri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gelesis LLC
Original Assignee
Gelesis LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelesis LLC filed Critical Gelesis LLC
Priority to US14/150,430 priority Critical patent/US20140296507A1/en
Publication of US20140296507A1 publication Critical patent/US20140296507A1/en
Priority to US15/185,443 priority patent/US10086014B2/en
Priority to US16/546,722 priority patent/US20200046755A1/en
Priority to US17/333,424 priority patent/US20210353665A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/262Cellulose; Derivatives thereof, e.g. ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/20Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246Intercrosslinking of at least two polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738Cross-linked polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/005Crosslinking of cellulose derivatives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C08B15/04Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/08Cellulose derivatives
    • C08J2301/26Cellulose ethers
    • C08J2301/28Alkyl ethers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/30Fuel from waste, e.g. synthetic alcohol or diesel
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02WCLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W30/00Technologies for solid waste management
    • Y02W30/40Bio-organic fraction processing; Production of fertilisers from the organic fraction of waste or refuse

Definitions

  • the present invention relates to polymer hydrogels and methods of preparation thereof.
  • Polymer hydrogels are cross-linked hydrophilic polymers which are capable of absorbing high amounts of water.
  • cross-linked polymer hydrogels capable of absorbing an amount of water in excess of 10 times their dry weight are defined as “superabsorbent”. Some of these materials are even capable of absorbing over 1 litre of water per gram of dry polymer.
  • cross-links or cross-linking knots i.e. the physical or chemical bonds between the macromolecular chains forming the polymer hydrogel network, guarantee the structural integrity of the polymer-liquid system, on the one hand preventing the complete solubilisation of the polymer, and on the other hand allowing the retention of the aqueous phase within the molecular mesh.
  • the superabsorbent polymer hydrogels which are currently available on the market are characterised not only by their marked absorbent properties, but also by their biocompatibility, which is probably due to the high water content, and, above all, by the possibility of adjusting their absorption properties according to the external stimuli. Consequently, such polymer hydrogels may be used as intelligent materials, for example for the manufacture of sensors or actuators for a number of industrial applications.
  • absorbent cores in the field of personal hygiene absorbent products there are more recent and innovative applications such as for example in the biomedical field, for the development of controlled release drug formulations, artificial muscles, sensors, etc., and in agriculture and horticulture, for example in devices for the controlled release of water and nutrients in arid soils.
  • biodegradable polymers used to obtain superabsorbent polymer hydrogels are starch and cellulose derivatives.
  • Anbergen and Oppermann proposed a method for the synthesis of a superabsorbent material made entirely from cellulose derivatives.
  • HEC hydroxyethylcellulose
  • CMCNa carboxymethylcellulose sodium salt
  • the absorption properties of such materials are not high compared to those of the acrylic-based superabsorbent materials.
  • CMCNa may be chemically cross-linked with any reagent which is bifunctional with respect to cellulose.
  • any reagent which is bifunctional with respect to cellulose.
  • divinylsulphone used in the synthetic process according to Anbergen and Opperman
  • epichlorohydrin, formaldehyde and various diepoxides have also been used as cross-linking agents.
  • such compounds are highly toxic in their unreacted states [3].
  • Some carbodiimides are known amongst the unconventional cross-linking agents. Particularly, the use of carbodiimides in order to cross-link salified or non-salified carboxymethylcellulose (CMC) was described in [4].
  • Carbodiimides induce the formation of ester bonds between cellulose macromolecules without participating in the bonds themselves, instead giving rise to a urea derivative having very low toxicity [5].
  • a superabsorbent polymer hydrogel obtained by cross-linking carboxymethylcellulose sodium salt and hydroxyethylcellulose with carbodiimide as the cross-linking agent is disclosed in the international patent application WO 2006/070337 [6].
  • the object of the present invention is to provide polymer hydrogels which overcome the above-mentioned disadvantages associated with the use of carbodiimide as a cross-linking agent.
  • the polymer hydrogels of the invention are based on the use of a polycarboxylic acid, such as citric acid, as the cross-linking agent, and in preferred embodiments, also include the use of a molecular spacer.
  • a polycarboxylic acid such as citric acid
  • the invention relates, in part, to the discovery that the cross-linking of soluble cellulose derivatives with citric acid (3-carboxy-3-hydroxy-1,5-pentanedioic acid; hereinafter designated “CA”) results in the formation of polymer hydrogels and superabsorbent polymer hydrogels.
  • CA is naturally occurring, non-toxic and available on the market at low cost.
  • CA has been reported as a cross-linking agent for polymers such as cellulose, hydroxypropylmethylcellulose and starch, in textile and food applications [7-11], in these applications CA is used to cross-link and further stabilize insoluble fibers, to provide a fabric with enhanced resiliency and mechanical properties.
  • CA to cross-link carboxymethylcellulose or other soluble hydrophilic polymers for preparing polymer hydrogels and superabsorbent polymer hydrogels has not been previously disclosed.
  • the method of preparing a polymer hydrogel according to the present invention comprises the step of cross-linking an aqueous solution comprising a hydrophilic polymer with a polycarboxylic acid, optionally in the presence of a compound which functions as a molecular spacer.
  • the aqueous solution comprises two or more hydrophilic polymers, such as, for example, hydroxylated polymers.
  • the aqueous solution can comprise a first hydrophilic polymer and a second hydrophilic polymer, which can be present in the same or different amounts on a weight basis.
  • the first hydrophilic polymer is an ionic polymer and the second polymer is a nonionic polymer.
  • the invention provides a method for preparing a polymer hydrogel, comprising the steps of (a) providing an aqueous solution of carboxymethylcellulose, hydroxyethylcellulose, citric acid and a molecular spacer; (b) heating the aqueous solution, thereby evaporating the water and cross-linking the carboxymethylcellulose and hydroxyethylcellulose to form a polymer hydrogel material; (c) washing the polymer hydrogel material with water or a polar organic solvent to form a washed polymer hydrogel; (d) immersing the washed polymer hydrogel in a cellulose nonsolvent, thereby producing a dried polymer hydrogel.
  • the present invention provides polymer hydrogels, such as superabsorbent polymer hydrogels, which can be prepared using the methods of the invention.
  • polymer hydrogels comprise at least one hydrophilic polymer cross-linked with a polycarboxylic acid.
  • the invention includes articles of manufacture which comprise such polymer hydrogels.
  • FIG. 1 illustrates the proposed mechanism of polymer cross-linking by citric acid.
  • FIG. 2 is a graph of cumulative food intake as a function of time for rats administered a polymer hydrogel of the invention orally and rats administered vehicle only.
  • the present invention provides polymer hydrogels, methods of preparing the polymer hydrogels, methods of use of the polymer hydrogels and articles of manufacture comprising the polymer hydrogels.
  • the method of preparing a polymer hydrogel of the present invention comprises the step of cross-linking an aqueous solution comprising a hydrophilic polymer with a polycarboxylic acid, thereby producing the polymer hydrogel.
  • the aqueous solution comprises two or more hydrophilic polymers.
  • the aqueous solution can comprise a first hydrophilic polymer and a second hydrophilic polymer, which can be present in the same or different amounts on a weight basis.
  • the first hydrophilic polymer is an ionic polymer and the second polymer is a nonionic polymer.
  • the cross-linking reaction is preferably conducted at elevated temperature, for example, at a temperature greater than room temperature (25° C.).
  • the reaction can be conducted at a temperature from about 30° C. to about 150° C., preferably from about 50° C. to about 120° C.
  • the reaction solution is concentrated by removal of water. The removal of water can be accomplished, for example, by evaporation. In one embodiment, a fraction of the water is removed. In another embodiment, substantially all of the water is removed, thereby producing a dry residue.
  • the reaction mixture is maintained at elevated temperature for a period of time following removal of water to dryness.
  • hydrophilic polymer refers to a polymer which is substantially water-soluble and, preferably, includes monomeric units which are hydroxylated.
  • a hydrophilic polymer can be a homopolymer, which includes only one repeating monomeric unit, or a copolymer, comprising two or more different repeating monomeric units.
  • the hydrophilic polymer is hydroxylated, such as polyallyl alcohol, polyvinyl alcohol or a polysaccharide. Examples of suitable polysaccharides include substituted celluloses, substituted dextrans, starches and substituted starches, glycosaminoglycans, chitosan and alginates.
  • Polysaccharides which can be used include alkylcelluloses, such as C 1 -C 6 -alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose; substituted alkylcelluloses, including hydroxy-C 1 -C 6 -alkylcelluloses and hydroxy-C 1 -C 6 -alkyl-C 1 -C 6 -alkylcelluloses, such as hydroxyethylcellulose, hydroxy-n-propylcellulose, hydroxy-n-butylcellulose, hydroxypropylmethylcellulose, ethylhydroxyethylcellulose and carboxymethylcellulose; starches, such as corn starch, hydroxypropylstarch and carboxymethylstarch; substituted dextrans, such as dextran sulfate, dextran phosphate and diethylaminodextran; glycosaminoglycans, including heparin, hyaluronan, chondroitin, chondroitin s
  • ionic polymer refers to a polymer comprising monomeric units having an acidic functional group, such as a carboxyl, sulfate, sulfonate, phosphate or phosphonate group, or a basic functional group, such as an amino, substituted amino or guanidyl group.
  • an ionic polymer comprising acidic functional groups will be a polyanion, and such a polymer is referred to herein as an “anionic polymer”.
  • an ionic polymer comprising basic functional groups will be a polycation.
  • a polymer is referred to herein as a “cationic polymer”.
  • ionic polymer, anionic polymer and cationic polymer refer to hydrophilic polymers in which the acidic or basic functional groups are not charged, as well as polymers in which some or all of the acidic or basic functional groups are charged, in combination with a suitable counterion.
  • Suitable anionic polymers include alginate, dextran sulfate, carboxymethylcellulose, hyaluronic acid, polyglucuronic acid, polymanuronic acid, polygalacturonic acid, polyarabinic acid; chrondroitin sulfate and dextran phosphate.
  • Suitable cationic polymers include chitosan and dimethylaminodextran.
  • a preferred ionic polymer is carboxymethylcellulose, which can be used in the acid form, or as a salt with a suitable cation, such as sodium or potassium.
  • nonionic polymer refers to a hydrophilic polymer which does not comprise monomeric units having ionizable functional groups, such as acidic or basic groups. Such a polymer will be uncharged in aqueous solution.
  • suitable nonionic polymers for use in the present method are polyallylalcohol, polyvinylalcohol, starches, such as corn starch and hydroxypropylstarch, alkylcelluloses, such as C 1 -C 6 -alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose; substituted alkylcelluloses, including hydroxy-C 1 -C 6 -alkylcelluloses and hydroxy-C 1 -C 6 -alkyl-C 1 -C 6 -alkylcelluloses, such as hydroxyethylcellulose, hydroxy-n-propylcellulose, hydroxy-n-butylcellulose, hydroxypropylmethylcellulose, and ethylhydroxyethylcellulose.
  • alkylcelluloses such as C 1 -C 6 -alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose
  • substituted alkylcelluloses including hydroxy-C 1 -C 6
  • polycarboxylic acid refers to an organic acid having two or more carboxylic acid functional groups, such as dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids, and also includes the anhydride forms of such organic acids.
  • Dicarboxylic acids include oxalic acid, malonic acid, maleic acid, malic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, phthalic acid, o-phthalic acid, isophthalic acid, m-phthalic acid, and terephthalic acid.
  • Preferred dicarboxylic acids include C 4 -C 12 -dicarboxylic acids.
  • Suitable tricarboxylic acids include citric acid, isocitric acid, aconitic acid, and propane-1,2,3-tricarboxylic acid.
  • Suitable tetracarboxylic acids include pyromellitic acid, 2,3,3′,4′-biphenyltetracarboxylic acid, 3,3′,4,4′-tetracarboxydiphenylether, 2,3′,3,4′-tetracarboxydiphenylether, 3,3′,4,4′-benzophenonetetracarboxylic acid, 2,3,6,7-tetracarboxynaphthalene, 1,4,5,7-tetracarboxynaphthalene, 1,4,5,6-tetracarboxynaphthalene, 3,3′,4,4′-tetracarboxydiphenylmethane, 2,2-bis(3,4-dicarboxyphenyl)propane, butanetetracarboxylic acid, and cyclopentanetetracarboxylic acid.
  • a particularly preferred polycarboxylic acid is citric acid.
  • the method can further include the steps of purifying the polymer hydrogel, for example, by washing the polymer hydrogel in a polar solvent, such as water, a polar organic solvent, for example, an alcohol, such as methanol or ethanol, or a combination thereof.
  • a polar solvent such as water
  • a polar organic solvent for example, an alcohol, such as methanol or ethanol, or a combination thereof.
  • the polymer hydrogel immersed in the polar solvent swells and releases any component, such as by-products or unreacted polycarboxylic acid that was not incorporated into the polymer network.
  • Water is preferred as the polar solvent, distilled water is still more preferred.
  • the volume of water required during this step to reach the maximum swelling degree of the gel is approximately 10- to 20-fold greater than the initial volume of the gel itself.
  • the polymer hydrogel washing step may be repeated more than once, optionally changing the polar solvent employed.
  • the polymer hydrogel can be washed with methanol or ethanol followed by distilled water, with these two steps optionally repeated one or more times.
  • the method can further include drying of the polymer hydrogel.
  • the drying step is carried out by immersing the fully swollen polymer hydrogel in a cellulose nonsolvent, a process known as phase inversion.
  • a cellulose nonsolvent include, for example, acetone and ethanol. Drying the polymer hydrogel by phase inversion results in a final microporous structure which improves the absorption properties of the polymer hydrogel by capillarity. Moreover, if the porosity is interconnected or open, i.e. the micropores communicate with one another, the absorption/desorption kinetics of the gel will be improved as well.
  • acetone/water mixture is formed which increases in water content as the polymer hydrogel dries; at a certain acetone/water concentration, for example, about 55% in acetone, water is no longer able to exit from the polymer hydrogel, and thus fresh acetone has to be added to the polymer hydrogel to proceed with the drying process.
  • acetone/water ratio the faster is the drying process.
  • Pore dimensions are affected by the rate of the drying process and the initial dimensions of the polymer hydrogel particles: larger particles and a faster process tend to increase the pore dimensions; pore dimensions in the microscale range are preferred, as pores in this size range exhibit a strong capillary effect, resulting in the higher sorption and water retention capacity.
  • the polymer hydrogels of the invention can also be dried by another process, such as air drying, freeze drying or oven drying. These drying methods can be used alone, in combination, or in combination with the non-solvent drying step described above.
  • the polymer hydrogel can be dried in a non-solvent, followed by air drying, freeze drying, oven drying, o a combination thereof to eliminate any residual traces of nonsolvent.
  • Oven drying can be carried out at a temperature of e.g. approximately 30-45° C. until the residual nonsolvent is completely removed.
  • the washed and dried polymer hydrogel can then be used as is, or can be milled to produce polymer hydrogel particles of a desired size.
  • the cross-linking solution can optionally include a compound which serves as a molecular spacer.
  • a “molecular spacer”, as this term is used herein, is a polyhydroxylated compound which, although not taking part in the reaction resulting in the formation of the cross-linked polymer hydrogel network to a significant extent, results in a polymer hydrogel with an increased absorption capacity. Although in certain cases the molecular spacer may participate in the cross-linking reaction to a small extent, it is believed that molecular spacers function by sterically blocking access to the polymer chains, thereby increasing the average distance between the polymer chains.
  • Suitable compounds for use as molecular spacers in the methods of the present invention include monosaccharides, disaccharides and sugar alcohols, including sucrose, sorbitol, plant glycerol, mannitol, trehalose, lactose, maltose, erythritol, xylitol, lactitol, maltitol, arabitol, glycerol, isomalt and cellobiose.
  • the molecular spacer is preferably included in the cross-linking solution in the amount of about 0.5% to about 10% by weight relative to the solvent, more preferably about 2% to about 8% and more preferably about 4%.
  • the molecular spacer used to synthesise the polymer hydrogel is selected from the group consisting of sorbitol, sucrose and plant glycerol.
  • sorbitol is used as the molecular spacer, at a concentration within the range of 0.5 to 10% by weight referred to the weight of water, preferably within the range of 2 to 8% by weight referred to the weight of water, still more preferably at a concentration of 4% by weight referred to the weight of water.
  • the aqueous solution includes an ionic polymer, preferably an anionic polymer, and most preferably, carboxymethylcellulose.
  • the anionic polymer is carboxymethylcellulose and the polycarboxylic acid is citric acid.
  • the aqueous solution includes an ionic polymer and a non-ionic polymer.
  • the ionic polymer is preferably an anionic polymer, and most preferably, carboxymethylcellulose.
  • the non-ionic polymer is preferably a substituted cellulose, more preferably a hydroxyalkylcellulose or a hydroxyalkyl alkylcellulose, and most preferably hydroxyethylcellulose (“HEC”).
  • the preferred polycarboxylic acid is citric acid.
  • the weight ratios of the ionic and non-ionic polymers can range from about 1:10 to about 10:1, preferably from about 1:5 to about 5:1. In preferred embodiments, the weight ratio is greater than 1:1, for example, from about 2 to about 5.
  • the ionic polymer is carboxymethycellulose
  • the non-ionic polymer is hydroxyethylcellulose
  • the weight ratio (ionic:nonionic) is about 3:1.
  • the total precursor concentration in the aqueous solution is of at least 2% by weight referred to the weight of the water of the starting aqueous solution, and the amount of the cross-linking agent is between about 1% and about 5% by weight referred to the weight of the precursor.
  • the term “precursor” indicates the hydrophilic polymer(s) used as the precursors for the formation of the polymer hydrogel polymer network, for example, in certain embodiments the “weight of the precursor” is the weight of CMCNa used or the combined weights of CMCNa and HEC used.
  • the aqueous solution preferably includes sorbitol in an amount of about 4% by weight relative to the weight of water.
  • the swelling ratio is a measure of the ability of the polymer hydrogel to absorb water. SR is obtained through swelling measurements at the equilibrium (using, for example, a Sartorius micro scale with a sensitivity of 10 ⁇ 5 ) and it is calculated with the following formula:
  • W s is the weight of the polymer hydrogel after immersion in distilled water for 24 hours
  • W d is the weight of the polymer hydrogel before immersion, the polymer hydrogel having been previously dried in order to remove any residual water.
  • the cross-linking reaction is preferably carried out at a temperature between about 60° C. and 120° C. Varying the temperature during this stage of the process will enable one to increase or decrease the cross-linking degree of the polymer network.
  • a cross-linking temperature of about 80° C. is preferred.
  • One particularly preferred embodiment of the method of the invention comprises the following steps: Step 1, the hydrophilic polymer(s), the carboxylic acid and, optionally, the molecular spacer are dissolved in water at room temperature; Step 2, the water is removed from the solution at 40° C. over a two-day period; Step 3, the product of Step 2 is heated to 80° C. for 10 hours to induce the cross-linking reaction and form a polymer hydrogel; Step 4, the polymer hydrogel is washed three times with water over 24 hours; Step 5, the washed polymer hydrogel is immersed in acetone for 24 hours to remove water; Step 6, the polymer hydrogel is further dried in an oven at 45° C. for 5 hours; and Step 7, the dried polymer hydrogel is milled to provide polymer hydrogel particles.
  • the present invention also provides polymer hydrogels which can be prepared using the methods of the invention.
  • Such polymer hydrogels comprise a hydrophilic polymer cross-linked with a polycarboxylic acid.
  • the polymer hydrogels of the invention include at least two hydrophilic polymers cross-linked by a polycarboxylic acid.
  • the polymer hydrogel comprises an ionic polymer and a non-ionic polymer and a polycarboxylic acid, preferably a C 4 to C 12 -dicarboxylic acid, a tricarboxylic acid or a tetracarboxylic acid, where the polycarboxylic acid cross-links the ionic polymer and the non-ionic polymer.
  • the weight ratio of ionic polymer to non-ionic polymer is preferably from about 1:5 to about 5:1, more preferably from about 2:1 to about 5:1, and most preferably about 3:1.
  • the ionic polymer is carboxymethylcellulose
  • the non-ionic polymer is hydroxyethylcellulose
  • the polycarboxylic acid is citric acid.
  • the polymer hydrogel comprises an ionic polymer, for example, an anionic polymer or a cationic polymer. More preferably, the ionic polymer is carboxymethylcellulose or a salt thereof, such as sodium carboxymethylcellulose.
  • the polymer hydrogel comprises carboxymethylcellulose cross-linked with citric acid.
  • the polymer hydrogels of the invention have swelling ratios of at least about 5.
  • the polymer hydrogels of the invention are superabsorbent polymer hydrogels, for example, polymer hydrogels having an SR of at least 10.
  • the polymer hydrogels of the invention have SRs at least about 20, about 30, about 40, about 50, about 60, about 70, about 80, about 90 or about 100.
  • the polymer hydrogels of the invention have SRs from about 10 to about 100, from about 20 to about 100, from about 30 to about 100, from about 40 to about 100, from about 50 to about 100, from about 60 to about 100, from about 70 to about 100, from about 80 to about 100, or from about 90 to about 100.
  • the invention includes polymer hydrogels having SRs up to 150, 200, 250, 300, 330 or 350.
  • the polymer hydrogels of the invention can absorb an amount of one or more bodily fluids, such as blood, blood plasma, urine, intestinal fluid or gastric fluid, which is at least 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 times their dry weight.
  • the ability of the polymer hydrogel to absorb bodily fluids can be tested using conventional means, including testing with samples of bodily fluids obtained from one or more subjects or with simulated bodily fluids, such as simulated urine or gastric fluid.
  • the polymer hydrogels can absorb significant amounts of a fluid prepared by combining one volume of simulated gastric fluid (SGF) with eight volumes of water. SGF can be prepared using USP Test Solutions procedures which are known in the art.
  • the polymer hydrogels of the invention can absorb at least about 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 or more times their dry weight of this SGF/water mixture.
  • the polymer hydrogels of the invention include cross-linked polymers having varying extents of hydration.
  • the polymer hydrogels can be provided in a state of hydration ranging from a substantially dry or anhydrous state, such as a state in which from about 0% to about 5% of the polymer hydrogel by weight is water or an aqueous fluid, to states comprising a substantial amount of water or aqueous fluid, including up to a state in which the polymer hydrogel has absorbed a maximum amount of water or an aqueous fluid.
  • the polymer hydrogels of the invention can be used in methods for treating obesity, reducing food or calorie intake or achieving or maintaining satiety.
  • the methods comprise the step of administering an effective amount of a polymer hydrogel of the invention to the stomach of a subject, preferably by causing the subject, such as a mammal, including a human, to ingest the polymer hydrogel.
  • Such polymer hydrogels can be used to take up stomach volume, for example, by increasing the volume of a food bolus without adding to the calorie content of the food.
  • the polymer hydrogel can be ingested by the subject prior to eating or in combination with food, for example, as a mixture of the polymer hydrogel with food.
  • the polymer hydrogel Upon ingestion and contact with gastric fluid or a combination of gastric fluid and water, the polymer hydrogel will swell.
  • the polymer hydrogel can be ingested alone or in a mixture with liquid or dry food in a dry, partially swollen or fully swollen state, but is preferably ingested in a state of hydration which is significantly below its fluid capacity, more preferably the polymer hydrogel is ingested in an anhydrous state.
  • the volume of the stomach taken up by the polymer hydrogel can be significantly greater than the volume of the polymer hydrogel ingested by the subject.
  • the polymer hydrogels of the invention can also take up volume and/or exert pressure on the wall of the small intestine by moving from the stomach into the small intestine and swelling.
  • the polymer hydrogel will remain swollen in the small intestine for a period of time sufficient to inhibit the intake of food by the subject, before shrinking sufficiently for excretion from the body.
  • the time sufficient to inhibit the intake of food by the subject will generally be the time required for the subject to eat and for the ingested food to pass through the small intestine, Such shrinking can occur, for example, by degradation through loss of cross-links, releasing fluid and decreasing in volume sufficiently for excretion from the body.
  • Preferred polymers for use in this method exhibit pH-dependent swelling, with greater swelling observed at higher pH than at lower pH.
  • a polymer will not swell significantly in the stomach unless food and/or water is present to raise the pH of the stomach contents and will move into the small intestine.
  • the polymer hydrogel When ingested with food, the polymer hydrogel will initially swell in the stomach, then shrink when the stomach is emptied of food and the pH drops and then move from the stomach to the small intestine. In the higher pH environment of the small intestine the polymer hydrogel will swell, taking up volume in the small intestine and/or exerting pressure on the wall of the small intestine.
  • the polymer hydrogel can optionally be administered in combination with a pH modifying agent, which is an agent which alters the pH of the microenvironment of the polymer hydrogel, thereby modifying its ability to absorb fluids.
  • a pH modifying agent which is an agent which alters the pH of the microenvironment of the polymer hydrogel, thereby modifying its ability to absorb fluids.
  • agents which increase the pH of the microenvironment can increase the swellability of the polymer hydrogel.
  • Suitable pH modifying agents for use with the polymer hydrogels of the invention include buffering agents, H 2 blockers, proton pump inhibitors, anatacids, proteins, nutritional shakes, and combinations thereof.
  • Suitable buffering agents and antacids include ammonium bicarbonate, sodium bicarbonate, calcium carbonate, calcium hydroxide, aluminium hydroxide, aluminium carbonate, magnesium carbonate, magnesium hydroxide, potassium bicarbonate, potassium carbonate, potassium hydroxide, sodium carbonate, sodium hydroxide and combinations thereof.
  • Suitable H 2 blockers include cimetidine, ranitidine, famotidine, nizatidine and combinations thereof.
  • Suitable proton pump inhibitors include omeprazole, lansoprazole, esorneprazole, pantoprazole, abeprazole, and combinations thereof.
  • the present polymer hydrogels can also be used for removing water from the gastrointestinal tract, for example, as a treatment for subjects suffering from kidney disease, including chronic and acute kidney disease, particularly subjects undergoing kidney dialysis.
  • the polymer hydrogels can further be used to modify the fluid content in the gastrointestinal tract of a subject in need thereof, for example, for the treatment of constipation.
  • the invention further includes articles of manufacture which comprise the polymer hydrogels of the invention.
  • articles of manufacture include articles in which polyacrylic polymer hydrogels are conventionally used, in consumer products, such as for example absorbent products for personal care (i.e., babies' napkins, sanitary towels, etc.) and in products for agriculture (e.g., devices for the controlled release of water and nutrients).
  • absorbent products for personal care i.e., babies' napkins, sanitary towels, etc.
  • products for agriculture e.g., devices for the controlled release of water and nutrients.
  • the absorption properties of the polymer hydrogels of the invention which in some embodiments depend on the amount of carboxymethylcellulose employed and which can be improved by the induction of a microporosity in the gel structure, are comparable to those of polyacrylic gels.
  • the polymer hydrogels obtainable by the method of the present invention therefore possess mechanical properties which make them suitable for use in all of the above-mentioned fields.
  • the present polymer hydrogels have advantages over acrylic polymer hydrogels, such as biodegradability, the absence of any toxic by-products during the manufacturing process and the use of fewer and readily available reagents. Such features enable a real employment of the polymer hydrogels of the invention in the biomedical and pharmaceutical fields as well.
  • the scope of the present invention also includes the use of the polymer hydrogels obtainable by the method of the invention as an absorbent material in products which are capable of absorbing water and/or aqueous solutions and/or which are capable of swelling when brought into contact with water and/or an aqueous solution.
  • polymer hydrogels and superabsorbent polymer hydrogels of the present invention may be used as absorbent materials in the following fields, which are provided by way of non-limiting example:
  • dietary supplements for example, as the bulking agents in dietary supplements for hypocaloric diets capable of conferring a sensation of lasting satiety being retained into the stomach for a limited period of time, or as water and low molecular weight compounds supplements, such as mineral salts or vitamins, to be included into drinks in a dry or swollen form;
  • agricultural products for example, in devices for the controlled release of water and/or nutrients and/or phytochemicals, particularly for cultivation in arid, deserted areas and in all cases where it is not possible to carry out frequent irrigation; such products, mixed in a dry form with the soil in the areas surrounding the plant roots, absorb water during irrigation and are capable of retaining it, releasing it slowly in certain cases, together with the nutrients and phytochemicals useful for cultivation);
  • toys and gadgets such as for example in products which are capable of significantly changing their size once brought into contact with water or an aqueous solution
  • biomedical field for example, in biomedical and/or medical devices such as absorbent dressings for the treatment of highly exudative wounds, such as ulcers and/or burns, or in slow-release polymeric films suitable to slowly release liquids adapted for use in ophthalmology; and
  • the body fluid management field i.e., for controlling the amount of liquids into the organism, for example in products capable of promoting the elimination of fluids from the body, such as, for example, in the case of edema, CHF (chronic heart failure), dialysis.
  • CHF chronic heart failure
  • the invention further includes the use of any of the polymer hydrogels of the invention in medicine.
  • Such use includes the use of a polymer hydrogel in the preparation of a medicament for the treatment of obesity or any medical disorder or disease in which calorie restriction has a therapeutic, palliative or prophylactic benefit.
  • CMCNa (MW 700 kDa, DS 0.9, food grade), HEC (MW 250 kDa, food grade) were purchased from Eigenmann e Veronelli S.p.A. Milano and citric acid was supplied by Dal Cin S.p.A. Sesto San Giovanni Milano and used as received.
  • Polymer hydrogel samples were obtained by reacting, in water, CMCNa and HEC with citric acid as a cross-linking agent according the following procedure.
  • CMCNa and HEC citric acid as a cross-linking agent
  • a total polymer concentration of 2% by weight of water, using a mixture of CMCNa and HEC, with weight ratio equal to 3/1 was dissolved in distilled water by stirring gently at room temperature until a clear solution was obtained.
  • Poor cross-linking efficiency has been reported if only CMCNa is used, due both to the electrostatic repulsion between polyelectrolyte chains and to the high degree of substitution of hydroxyl groups at C6, the 2.5 most reactive position [13].
  • CMCNa dissolution is slow at the concentration adopted; thus, first HEC was added to water till, after 5 min, a clear solution was obtained with a slight increase of viscosity; then, CMCNa was added, and the stirring was kept on till a clear solution was obtained (24 h), with a significant increase of viscosity. Finally, CA was added at different concentrations (1.75%, 2.75%, 3.75%, 10% and 20% w/w polymer) in order to obtain samples with various degrees of cross-linking. This final solution was used to mold 10 mm thick samples. All samples were first pre-dried at 30° C. for 24 h to remove absorbed water and then kept at 80° C. for the cross-linking reaction (24 h with intermediate control).
  • samples containing neat HEC or neat CMCNa samples cross-linked with CA were also prepared following exactly the same experimental conditions used for HEC/CMCNa mixtures.
  • W s is the weight of the swollen polymer hydrogel and W d is the weight of the dried sample [15].
  • a differential scanning calorimeter (Mettler-Toledo 822 e Mettler DSC) was used for thermal analysis.
  • the scanning temperature range and the heating rate were 10-200° C. and 5° C./min, respectively.
  • the adopted thermal cycle was: (1) heating 10-100° C.; (2) isotherm at 100° C. for 3 minutes; (3) cooling from 100° C. to 10° C.; (4) heating from 10° C. to 200° C.; (5) isotherm at 200° C.; (6) cooling until room temperature.
  • An empty pan was used as a reference.
  • FT IR spectra were recorded on a JASCO FT IR 660 plus spectrometer equipped with an attenuated total reflectance (ATR) crystal sampler. Film samples were used directly on a ATR crystal sampler at a resolution of 4 cm ⁇ 1 , by 300 scans, at absorbance range from 4000 cm ⁇ 1 to 600 cm ⁇ 1 .
  • ATR attenuated total reflectance
  • a DSC thermogram of neat citric acid showed a peak at about 60° C., attributable to a water loss process associated with the dehydration leading to an anhydride. A complete degradation, starting at about 160° C., is observed in the second scan.
  • CMCNa and HEC powders DSC analysis of neat CMCNa and HEC powders indicates that some water is still absorbed in the polymers. Above 100° C. a possible degradation peak of CMCNa is detected. Both CMCNa and HEC show a thermal stability below 100° C.
  • a film of polymer hydrogel obtained using a 3:1 ratio of CMCNa/HEC and 3.75% by weight of polymer of citric acid was analyzed by DSC after drying the sample at 30° C. for 24 h and then reduced to powder.
  • a large endothermic peak associated to the evaporation of the water produced by the anhydrification process is evident.
  • a small exothermic peak, attributed to esterification is superimposed on the first one.
  • T g 38° C.
  • CMCNa and HEC were cross-linked with CA in order to investigate its reactivity with each of the polymers.
  • FT IR spectra were recorded of citric acid, of the A10 reaction mixture before heating and of the A10 reaction mixture after 5 h of heating.
  • CA spectrum it is possible to observe a strong C ⁇ O band centred at 1715 cm ⁇ 1 due to carboxylic acid.
  • the FT IR spectrum of sample A10 shows a strong absorption band at 1590 cm ⁇ 1 characteristic of cellulose [16]. After heating, the absorbance band at about 1590 cm ⁇ 1 is still observed and additionally a new band at 1738 cm ⁇ 1 appears
  • Anhydrides display two stretching bands in the carbonyl region around 1758 cm ⁇ 1 and 1828 cm ⁇ 1 .
  • the higher frequency band is the more intense in acyclic anhydrides whereas cyclic anhydrides show the lower frequency C ⁇ O stretching band stronger than the stretching band at higher frequency [14].
  • the new peak observed at 1738 cm ⁇ 1 can be attributed to the characteristic stretching band of the carbonyl group at lower frequency related to anhydride formation, an intermediate reaction necessary for reaction of CA with cellulose hydroxyl groups. In contrast, the carbonyl peak expected at higher frequency is not detectable probably due to its weak intensity.
  • FT IR spectra were recorded of citric acid, B10 reaction mixture before heating and B10 reaction mixture after 6.5 h of heating.
  • the HEC spectrum again shows the band at 1590 cm ⁇ 1 before and after heating while the absorbance of the carbonyl group at 1738 cm ⁇ 1 appears only after heating at 80° C. as observed for the sample A10.
  • the evolution of the anhydride was evaluated as the ratio of A 1 /A 2 as a function of the reaction time.
  • FTIR spectra of CMCNa polymer when the reaction is performed at 80° C. with 20% CA or 10% CA both show a similar trend: the anhydride band, that is absent before heating, reaches a maximum almost immediately after the first hour, successively decreases to a minimum after 3 h, then increasing again reaching a second maximum after 5 h.
  • FTIR spectra were also recorded for reactions of HEC polymer when the reaction is performed at 80° C. with either 20% CA or 10% CA.
  • the anhydride band intensity increases from 0 to 0.098 when the reaction time increase from 0 h to 6.5 h, but drops to 0 when the reaction time reaches 24 h.
  • the 20% CA reaction follows exactly the same trend providing a maximum value of 0.079 at 5 h.
  • the cross-linking mechanism is the same as described for CMCNa
  • the anhydrification and esterification reactions appear superimposed in this case. Therefore, in the FTIR spectra, the HEC polymer shows a single peak. This latter result was in accordance with conclusion of Xie and co-workers [18]. They studied the degree of substitution, as evaluation of cross-linking esterification, on starch thermally reacted with CA at different reaction time and found a maximum after a few hours.
  • CMCNa has carboxylic acid functional groups in its structure that increase the volume variation process in solution.
  • Reaction sample C20 shows similar spectra.
  • polymer mixtures are used (C10 and C20) a broad signal appears at about 1715 cm ⁇ 1 , especially when a higher CA concentration is used in the reaction.
  • the FT IR spectrum shows a broad band in the range of 1711 cm ⁇ 1 -1736 cm ⁇ 1 and after 13 h this band appears more clearly as a narrow absorbance band at 1737 cm ⁇ 1 , which is typical of carbonyl groups.
  • Spectra of C20 reaction provide similar results. Although a quantitative analysis of carbonyl groups is not possible when C10 and C20 samples are cross-linked, an evaluation of the carbonyl peak similar to those observed for the reaction of the neat polymers can be assumed.
  • the cross-linking kinetics were also monitored studying the swelling behaviour during the reaction progress. Swelling ratio was calculated as a function of the reaction time for: (a) CMCNa with 10% or 20% of CA concentration; (b) HEC with 10% or 20% of CA concentration; (c) the mixture of CMCNa and HEC (3/1) with 10% or 20% CA concentration; (d) the mixture of CMCNa and HEC (3/1) with 1.75%, 2.75% or 3.75% CA concentration.
  • CMCNa/CA sample The maximum swelling of CMCNa/CA sample is observed at the gelation onset, after 3 h, when the second esterification reaction, those leading to cross-linking, begins. Then as the cross-linking process increases the corresponding equilibrium water sorption decreases, confirming the results of FTIR analysis.
  • Polymer hydrogels of practical use presenting a high degree of swelling were obtained with a reduced concentration of citric acid (1.75%, 2.75%, 3.75% by weight of polymer). With a citric acid concentration of 3.75% the swelling ratio can reach 900.
  • This polymer hydrogel, after swelling, is characterized by adequate stiffness and it is able to keep the same shape of the synthesis vat.
  • Polymer hydrogels formerly synthesized [13] using divinyl sulfone, a toxic reagent, as cross-linking agents and the same ratio between CMCNa and HEC were characterized by a maximum swelling ratio of 200. In this case a higher swelling ratio is obtained using an environmentally friendly cross-linking agent. At concentrations lower than 1.75% CA, a weak cross-linking associated with insufficient mechanical property is observed.
  • the cross-linking reaction for CMCNa/HEC system was observed either by DSC or by FTIR analysis.
  • the evolution of the different cross-linking reactions was monitored by means of FT IR spectra collected at different reaction times using an excess of citric acid.
  • An optimal degree of swelling (900) for practical applications was achieved using low CA concentrations.
  • the polymer hydrogel obtained through the method described in this Example 1 has the great advantage to reduce primary and production costs and avoid any toxic intermediate during its synthetic process.
  • the polymer hydrogels were prepared by cross-linking an aqueous solution of carboxymethylcellulose sodium salt (CMCNa) and hydroxyethylcellulose (HEC), using citric acid (CA) as the cross-linking agent and sorbitol as the molecular spacer.
  • CMCNa carboxymethylcellulose sodium salt
  • HEC hydroxyethylcellulose
  • CA citric acid
  • sorbitol sorbitol
  • the precursor weight concentration (%) the total mass of polymers in the solution (e.g. CMCNa+HEC) (g) ⁇ 100/mass of water (g);
  • the CMCNa to HEC weight ratio mass of CMCNa (g) in the solution/mass of HEC in the solution (g);
  • the cross-linking agent (CA) weight concentration (%) mass of CA in the solution (g) ⁇ 100/mass of the precursors in the solution (g);
  • the molecular spacer (e.g. sorbitol) weight concentration (%) mass of molecular spacer (g) ⁇ 100/mass of water (g).
  • CMCNa is the ionic polymer species, it is possible to achieve the desired absorption properties adjusting the weight ratio of carboxymethylcellulose sodium salt (CMCNa) to hydroxyethylcellulose (HEC).
  • CMCNa/HEC weight ratio of between 0/1 and 5/1, preferably between 1/1 and 3/1, was observed to enable the synthesis of a polymer hydrogel having optimum absorption properties.
  • sorbitol at a concentration of 4% by weight referred to the weight of distilled water was added and mixed until complete solubilisation, which occurred within a few minutes.
  • the CMCNa and HEC polymers are added at a total concentration of 2% by weight referred to the weight of distilled water, with a CMCNa/HEC weight ratio of 3/1. Mixing proceeded until solubilisation of the whole quantity of polymer is achieved and the solution became clear.
  • citric acid at a concentration of 1% by weight referred to the weight of the precursor was added to the solution, whose viscosity had greatly increased.
  • the solution thereby obtained was poured into a vessel and dried at 48° C. for 48 hours.
  • the macromolecules are stabilised into a polymeric network which is the backbone of the polymer hydrogel.
  • the polymer hydrogel was washed with distilled water for 24 hours at room temperature. During this phase, the polymer hydrogel swelled up thereby eliminating the impurities. In order to obtain the maximum swelling degree and elimination of all of the impurities, at least 3 rinses with distilled water were performed during the 24 hours washing step. At the end of this washing step, the polymer hydrogel was dried by phase inversion in acetone as the nonsolvent, until a glassy white precipitate is obtained. The precipitate is then placed into an oven at 45° C. for about 3 hours, to remove any residual trace of acetone.
  • Polymer hydrogel B was prepared as polymer hydrogel A, with the only exception that the polymer is made only of CMCNa, and that the CMCNa concentration is 2% by weight referred to the weight of distilled water.
  • Polymer hydrogel C was prepared as polymer hydrogel B, with the only exception that the citric acid concentration is 2% by weight referred to the weight of CMCNa.
  • Polymer hydrogel D was prepared as polymer hydrogel B, with the only exception that the citric acid concentration is 0.5% by weight referred to the weight of CMCNa.
  • the absorption measurements essentially consist of placing the dry sample, obtained from the drying step, in distilled water, so that it swells up until an equilibrium condition is reached.
  • the absorption properties of the gel are assessed based on its swelling ratio (SR), defined according to the formula illustrated above.
  • SR swelling ratio
  • Table 2 reports some of the results obtained, in terms of the swelling ratio, varying the concentrations of the reagents and the cross-linking times (6 hours, 13 hours, 18 hours, 24 hours).
  • Table 3 shows that the sample having the best swelling ratio is the sample designated as g22, which is characterised by a citric acid (CA) concentration of 1%.
  • CA citric acid
  • the possibility of increasing the swelling ratio by creating porosity into the material which could promote the absorbing properties was evaluated.
  • the sample g31 subjected to cross-linking for 12 hours, was swelled into distilled water for 24 hours and then dried by phase inversion in acetone. With this technique, a swelling ratio of 200 was obtained.
  • This example describes an evaluation of the superabsorbent polymer hydrogel denoted polymer hydrogel B in Example 2 in in vitro swelling and collapsing experiments in various media at 37° C.
  • SGF simulated gastric fluid
  • This polymer hydrogel swells in simulated gastric fluids (pH 1.5) approximately 15 fold, and in a simulated gastric fluids/water mixture (pH 3) approximately 85 fold. This indicates that the polymer hydrogel has a pH/swelling correlation where at pH below 3 (pKa of CMC is ⁇ 3.1) there will be limited swelling of the polymer hydrogel due to absence of the Donnan effect.
  • the polymer can also swell in the increased pH of simulated intestinal fluid.
  • FIG. 2 a graph of cumulative food intake as a function of time, represents a typical study result. There was no difference between the groups at base line. Gavage of 8 mL of polymer hydrogel B induced satiety in the rats that led to a significnt decrease in food intake. As shown in the yellow line, this polymer hydrogel induced a marked decrease in food intake that persisted over 2 hours. These data suggest that polymer hydrogel B can induce satiety in animals and leads to a decrease in food intake.

Abstract

The invention relates to a method for the preparation of a polymer hydrogel, comprising cross-linking a precursor comprising a hydrophilic polymer optionally in combination with a second hydrophilic polymer, using a polycarboxylic acid as the cross-linking agent. The invention further concerns the polymer hydrogel obtainable by the method of the invention and the use thereof in a number of different applications.

Description

    RELATED APPLICATION(S)
  • This application is a continuation of U.S. application Ser. No. 12/703,286, filed Feb. 10, 2010, which is a continuation of International Application No. PCT/EP2008/006582, which designated the United States and was filed on Aug. 8, 2008, published in English, which is a continuation-in-part of International Application No. PCT/IT2007/000584, which designated the United States and was filed on Aug. 10, 2007, published in English. The entire teachings of the above applications are incorporated herein by reference.
  • BACKGROUND OF THE INVENTION
  • The present invention relates to polymer hydrogels and methods of preparation thereof.
  • Polymer hydrogels are cross-linked hydrophilic polymers which are capable of absorbing high amounts of water. In particular, cross-linked polymer hydrogels capable of absorbing an amount of water in excess of 10 times their dry weight are defined as “superabsorbent”. Some of these materials are even capable of absorbing over 1 litre of water per gram of dry polymer.
  • The cross-links or cross-linking knots, i.e. the physical or chemical bonds between the macromolecular chains forming the polymer hydrogel network, guarantee the structural integrity of the polymer-liquid system, on the one hand preventing the complete solubilisation of the polymer, and on the other hand allowing the retention of the aqueous phase within the molecular mesh.
  • The superabsorbent polymer hydrogels which are currently available on the market are characterised not only by their marked absorbent properties, but also by their biocompatibility, which is probably due to the high water content, and, above all, by the possibility of adjusting their absorption properties according to the external stimuli. Consequently, such polymer hydrogels may be used as intelligent materials, for example for the manufacture of sensors or actuators for a number of industrial applications. Besides the usual applications as absorbent cores in the field of personal hygiene absorbent products, there are more recent and innovative applications such as for example in the biomedical field, for the development of controlled release drug formulations, artificial muscles, sensors, etc., and in agriculture and horticulture, for example in devices for the controlled release of water and nutrients in arid soils.
  • However, the superabsorbent polymer hydrogels currently available are almost exclusively acrylic-based products, and hence not biodegradable.
  • Given the growing interest in environmental protection issues, over recent years a vast amount of interest has been focussed on the development of superabsorbent materials based on biodegradable polymers, having properties which are similar to those of the traditional superabsorbent polyacrylics.
  • Examples of biodegradable polymers used to obtain superabsorbent polymer hydrogels are starch and cellulose derivatives.
  • In 1990 Anbergen and Oppermann [1] proposed a method for the synthesis of a superabsorbent material made entirely from cellulose derivatives. In particular, they used hydroxyethylcellulose (HEC) and a carboxymethylcellulose sodium salt (CMCNa), chemically cross-linked in a basic solution with divinylsulphone. However, the absorption properties of such materials are not high compared to those of the acrylic-based superabsorbent materials.
  • In 1996 Esposito and co-workers [2], studying the synthetic process proposed by Anbergen and Opperman, developed a method for increasing the absorption properties of the gel, acting mainly on the physical properties of the material. The basic idea was the induction of microporosity into the polymer structure, so as to promote absorption and retention of water by capillarity. Said microporosity was induced during the drying step, which was carried out by phase inversion in a nonsolvent for the polymer, and the absorption properties of the material thus obtained were markedly superior to those of the air-dried gel.
  • CMCNa may be chemically cross-linked with any reagent which is bifunctional with respect to cellulose. Besides the divinylsulphone used in the synthetic process according to Anbergen and Opperman, epichlorohydrin, formaldehyde and various diepoxides have also been used as cross-linking agents. However, such compounds are highly toxic in their unreacted states [3]. Some carbodiimides are known amongst the unconventional cross-linking agents. Particularly, the use of carbodiimides in order to cross-link salified or non-salified carboxymethylcellulose (CMC) was described in [4]. Carbodiimides induce the formation of ester bonds between cellulose macromolecules without participating in the bonds themselves, instead giving rise to a urea derivative having very low toxicity [5]. A superabsorbent polymer hydrogel obtained by cross-linking carboxymethylcellulose sodium salt and hydroxyethylcellulose with carbodiimide as the cross-linking agent is disclosed in the international patent application WO 2006/070337 [6].
  • However, the carbodiimide used as a cross-linking agent in WO 2006/070337 has the disadvantage of being extremely expensive. Moreover, during the cross-linking reaction with CMCNa, this substance turns into a slightly toxic urea derivative, which must be removed during the washing step, thereby further increasing the costs and the complexity of the production process. These drawbacks are extremely unfavourable, particularly in connection with those applications which require large scale production of the polymer hydrogels and which, consequently, involve high costs both with respect to the purchase of the starting materials and with respect to the disposal of the toxic substances which are produced during synthesis.
  • Furthermore, the formation of substances having a certain degree of toxicity, although very low, is a key factor for ruling out the possibility of using such polymers in biomedical and pharmaceutical applications.
  • SUMMARY OF THE INVENTION
  • The object of the present invention is to provide polymer hydrogels which overcome the above-mentioned disadvantages associated with the use of carbodiimide as a cross-linking agent.
  • These and other objects are achieved by the polymer hydrogels of the invention and the method of preparation thereof as defined herein. The polymer hydrogels of the invention are based on the use of a polycarboxylic acid, such as citric acid, as the cross-linking agent, and in preferred embodiments, also include the use of a molecular spacer.
  • The invention relates, in part, to the discovery that the cross-linking of soluble cellulose derivatives with citric acid (3-carboxy-3-hydroxy-1,5-pentanedioic acid; hereinafter designated “CA”) results in the formation of polymer hydrogels and superabsorbent polymer hydrogels. CA is naturally occurring, non-toxic and available on the market at low cost. Although CA has been reported as a cross-linking agent for polymers such as cellulose, hydroxypropylmethylcellulose and starch, in textile and food applications [7-11], in these applications CA is used to cross-link and further stabilize insoluble fibers, to provide a fabric with enhanced resiliency and mechanical properties. However, the use of CA to cross-link carboxymethylcellulose or other soluble hydrophilic polymers for preparing polymer hydrogels and superabsorbent polymer hydrogels has not been previously disclosed.
  • The method of preparing a polymer hydrogel according to the present invention comprises the step of cross-linking an aqueous solution comprising a hydrophilic polymer with a polycarboxylic acid, optionally in the presence of a compound which functions as a molecular spacer.
  • In one embodiment, the aqueous solution comprises two or more hydrophilic polymers, such as, for example, hydroxylated polymers. For example, the aqueous solution can comprise a first hydrophilic polymer and a second hydrophilic polymer, which can be present in the same or different amounts on a weight basis. In one embodiment, the first hydrophilic polymer is an ionic polymer and the second polymer is a nonionic polymer.
  • In one preferred embodiment, the invention provides a method for preparing a polymer hydrogel, comprising the steps of (a) providing an aqueous solution of carboxymethylcellulose, hydroxyethylcellulose, citric acid and a molecular spacer; (b) heating the aqueous solution, thereby evaporating the water and cross-linking the carboxymethylcellulose and hydroxyethylcellulose to form a polymer hydrogel material; (c) washing the polymer hydrogel material with water or a polar organic solvent to form a washed polymer hydrogel; (d) immersing the washed polymer hydrogel in a cellulose nonsolvent, thereby producing a dried polymer hydrogel.
  • In yet another embodiment, the present invention provides polymer hydrogels, such as superabsorbent polymer hydrogels, which can be prepared using the methods of the invention. Such polymer hydrogels comprise at least one hydrophilic polymer cross-linked with a polycarboxylic acid. Further, the invention includes articles of manufacture which comprise such polymer hydrogels.
  • BRIEF SUMMARY OF THE DRAWINGS
  • FIG. 1 illustrates the proposed mechanism of polymer cross-linking by citric acid.
  • FIG. 2 is a graph of cumulative food intake as a function of time for rats administered a polymer hydrogel of the invention orally and rats administered vehicle only.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention provides polymer hydrogels, methods of preparing the polymer hydrogels, methods of use of the polymer hydrogels and articles of manufacture comprising the polymer hydrogels.
  • The method of preparing a polymer hydrogel of the present invention comprises the step of cross-linking an aqueous solution comprising a hydrophilic polymer with a polycarboxylic acid, thereby producing the polymer hydrogel. In some embodiments, the aqueous solution comprises two or more hydrophilic polymers. For example, the aqueous solution can comprise a first hydrophilic polymer and a second hydrophilic polymer, which can be present in the same or different amounts on a weight basis. In preferred embodiments, the first hydrophilic polymer is an ionic polymer and the second polymer is a nonionic polymer.
  • The cross-linking reaction is preferably conducted at elevated temperature, for example, at a temperature greater than room temperature (25° C.). For example, the reaction can be conducted at a temperature from about 30° C. to about 150° C., preferably from about 50° C. to about 120° C. In one embodiment, while the cross-linking reaction is conducted at elevated temperature, the reaction solution is concentrated by removal of water. The removal of water can be accomplished, for example, by evaporation. In one embodiment, a fraction of the water is removed. In another embodiment, substantially all of the water is removed, thereby producing a dry residue. Optionally, the reaction mixture is maintained at elevated temperature for a period of time following removal of water to dryness.
  • As used herein, the term “hydrophilic polymer” refers to a polymer which is substantially water-soluble and, preferably, includes monomeric units which are hydroxylated. A hydrophilic polymer can be a homopolymer, which includes only one repeating monomeric unit, or a copolymer, comprising two or more different repeating monomeric units. In a preferred embodiment, the hydrophilic polymer is hydroxylated, such as polyallyl alcohol, polyvinyl alcohol or a polysaccharide. Examples of suitable polysaccharides include substituted celluloses, substituted dextrans, starches and substituted starches, glycosaminoglycans, chitosan and alginates.
  • Polysaccharides which can be used include alkylcelluloses, such as C1-C6-alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose; substituted alkylcelluloses, including hydroxy-C1-C6-alkylcelluloses and hydroxy-C1-C6-alkyl-C1-C6-alkylcelluloses, such as hydroxyethylcellulose, hydroxy-n-propylcellulose, hydroxy-n-butylcellulose, hydroxypropylmethylcellulose, ethylhydroxyethylcellulose and carboxymethylcellulose; starches, such as corn starch, hydroxypropylstarch and carboxymethylstarch; substituted dextrans, such as dextran sulfate, dextran phosphate and diethylaminodextran; glycosaminoglycans, including heparin, hyaluronan, chondroitin, chondroitin sulfate and heparan sulfate; and polyuronic acids, such as polyglucuronic acid, polymanuronic acid, polygalacturonic acid and polyarabinic acid.
  • As used herein, the term “ionic polymer” refers to a polymer comprising monomeric units having an acidic functional group, such as a carboxyl, sulfate, sulfonate, phosphate or phosphonate group, or a basic functional group, such as an amino, substituted amino or guanidyl group. When in aqueous solution at a suitable pH range, an ionic polymer comprising acidic functional groups will be a polyanion, and such a polymer is referred to herein as an “anionic polymer”. Likewise, in aqueous solution at a suitable pH range, an ionic polymer comprising basic functional groups will be a polycation. Such a polymer is referred to herein as a “cationic polymer”. As used herein, the terms ionic polymer, anionic polymer and cationic polymer refer to hydrophilic polymers in which the acidic or basic functional groups are not charged, as well as polymers in which some or all of the acidic or basic functional groups are charged, in combination with a suitable counterion. Suitable anionic polymers include alginate, dextran sulfate, carboxymethylcellulose, hyaluronic acid, polyglucuronic acid, polymanuronic acid, polygalacturonic acid, polyarabinic acid; chrondroitin sulfate and dextran phosphate. Suitable cationic polymers include chitosan and dimethylaminodextran. A preferred ionic polymer is carboxymethylcellulose, which can be used in the acid form, or as a salt with a suitable cation, such as sodium or potassium.
  • The term “nonionic polymer”, as used herein, refers to a hydrophilic polymer which does not comprise monomeric units having ionizable functional groups, such as acidic or basic groups. Such a polymer will be uncharged in aqueous solution. Examples of suitable nonionic polymers for use in the present method are polyallylalcohol, polyvinylalcohol, starches, such as corn starch and hydroxypropylstarch, alkylcelluloses, such as C1-C6-alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose; substituted alkylcelluloses, including hydroxy-C1-C6-alkylcelluloses and hydroxy-C1-C6-alkyl-C1-C6-alkylcelluloses, such as hydroxyethylcellulose, hydroxy-n-propylcellulose, hydroxy-n-butylcellulose, hydroxypropylmethylcellulose, and ethylhydroxyethylcellulose.
  • As used herein, the term “polycarboxylic acid” refers to an organic acid having two or more carboxylic acid functional groups, such as dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids, and also includes the anhydride forms of such organic acids. Dicarboxylic acids include oxalic acid, malonic acid, maleic acid, malic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, phthalic acid, o-phthalic acid, isophthalic acid, m-phthalic acid, and terephthalic acid. Preferred dicarboxylic acids include C4-C12-dicarboxylic acids. Suitable tricarboxylic acids include citric acid, isocitric acid, aconitic acid, and propane-1,2,3-tricarboxylic acid. Suitable tetracarboxylic acids include pyromellitic acid, 2,3,3′,4′-biphenyltetracarboxylic acid, 3,3′,4,4′-tetracarboxydiphenylether, 2,3′,3,4′-tetracarboxydiphenylether, 3,3′,4,4′-benzophenonetetracarboxylic acid, 2,3,6,7-tetracarboxynaphthalene, 1,4,5,7-tetracarboxynaphthalene, 1,4,5,6-tetracarboxynaphthalene, 3,3′,4,4′-tetracarboxydiphenylmethane, 2,2-bis(3,4-dicarboxyphenyl)propane, butanetetracarboxylic acid, and cyclopentanetetracarboxylic acid. A particularly preferred polycarboxylic acid is citric acid.
  • The method can further include the steps of purifying the polymer hydrogel, for example, by washing the polymer hydrogel in a polar solvent, such as water, a polar organic solvent, for example, an alcohol, such as methanol or ethanol, or a combination thereof. The polymer hydrogel immersed in the polar solvent swells and releases any component, such as by-products or unreacted polycarboxylic acid that was not incorporated into the polymer network. Water is preferred as the polar solvent, distilled water is still more preferred. The volume of water required during this step to reach the maximum swelling degree of the gel, is approximately 10- to 20-fold greater than the initial volume of the gel itself. Taking into account the substantial amounts of water which would be involved during this step on an industrial scale, as well as the disposal and/or recycling of the washes, the importance of avoiding the presence of any toxic by-products in the synthetic process becomes evident. The polymer hydrogel washing step may be repeated more than once, optionally changing the polar solvent employed. For example, the polymer hydrogel can be washed with methanol or ethanol followed by distilled water, with these two steps optionally repeated one or more times.
  • The method can further include drying of the polymer hydrogel. The drying step is carried out by immersing the fully swollen polymer hydrogel in a cellulose nonsolvent, a process known as phase inversion. Suitable cellulose nonsolvents include, for example, acetone and ethanol. Drying the polymer hydrogel by phase inversion results in a final microporous structure which improves the absorption properties of the polymer hydrogel by capillarity. Moreover, if the porosity is interconnected or open, i.e. the micropores communicate with one another, the absorption/desorption kinetics of the gel will be improved as well. When a completely or partially swollen gel is immersed into a nonsolvent, the gel undergoes phase inversion with the expulsion of water, until the gel precipitates in the form of a vitreous solid as white coloured particles. Various rinses in the nonsolvent may be necessary in order to obtain the dried gel in a short period of time. For example, when the swollen polymer hydrogel is immersed in acetone as the non-solvent, a water/acetone mixture is formed which increases in water content as the polymer hydrogel dries; at a certain acetone/water concentration, for example, about 55% in acetone, water is no longer able to exit from the polymer hydrogel, and thus fresh acetone has to be added to the polymer hydrogel to proceed with the drying process. The higher the acetone/water ratio during drying, the faster is the drying process. Pore dimensions are affected by the rate of the drying process and the initial dimensions of the polymer hydrogel particles: larger particles and a faster process tend to increase the pore dimensions; pore dimensions in the microscale range are preferred, as pores in this size range exhibit a strong capillary effect, resulting in the higher sorption and water retention capacity.
  • The polymer hydrogels of the invention can also be dried by another process, such as air drying, freeze drying or oven drying. These drying methods can be used alone, in combination, or in combination with the non-solvent drying step described above. For example, the polymer hydrogel can be dried in a non-solvent, followed by air drying, freeze drying, oven drying, o a combination thereof to eliminate any residual traces of nonsolvent. Oven drying can be carried out at a temperature of e.g. approximately 30-45° C. until the residual nonsolvent is completely removed. The washed and dried polymer hydrogel can then be used as is, or can be milled to produce polymer hydrogel particles of a desired size.
  • The cross-linking solution can optionally include a compound which serves as a molecular spacer. A “molecular spacer”, as this term is used herein, is a polyhydroxylated compound which, although not taking part in the reaction resulting in the formation of the cross-linked polymer hydrogel network to a significant extent, results in a polymer hydrogel with an increased absorption capacity. Although in certain cases the molecular spacer may participate in the cross-linking reaction to a small extent, it is believed that molecular spacers function by sterically blocking access to the polymer chains, thereby increasing the average distance between the polymer chains. Cross-linking, therefore, can occur at sites which are not close together, thereby enhancing the ability of the polymer network to expand so as to greatly increase the polymer hydrogel absorption properties. Suitable compounds for use as molecular spacers in the methods of the present invention include monosaccharides, disaccharides and sugar alcohols, including sucrose, sorbitol, plant glycerol, mannitol, trehalose, lactose, maltose, erythritol, xylitol, lactitol, maltitol, arabitol, glycerol, isomalt and cellobiose. The molecular spacer is preferably included in the cross-linking solution in the amount of about 0.5% to about 10% by weight relative to the solvent, more preferably about 2% to about 8% and more preferably about 4%.
  • According to a preferred embodiment of the invention, the molecular spacer used to synthesise the polymer hydrogel is selected from the group consisting of sorbitol, sucrose and plant glycerol.
  • According to a particularly preferred embodiment of the method of the invention, sorbitol is used as the molecular spacer, at a concentration within the range of 0.5 to 10% by weight referred to the weight of water, preferably within the range of 2 to 8% by weight referred to the weight of water, still more preferably at a concentration of 4% by weight referred to the weight of water.
  • In one embodiment, the aqueous solution includes an ionic polymer, preferably an anionic polymer, and most preferably, carboxymethylcellulose. In a particularly preferred embodiment the anionic polymer is carboxymethylcellulose and the polycarboxylic acid is citric acid.
  • In another embodiment, the aqueous solution includes an ionic polymer and a non-ionic polymer. The ionic polymer is preferably an anionic polymer, and most preferably, carboxymethylcellulose. The non-ionic polymer is preferably a substituted cellulose, more preferably a hydroxyalkylcellulose or a hydroxyalkyl alkylcellulose, and most preferably hydroxyethylcellulose (“HEC”). The preferred polycarboxylic acid is citric acid.
  • The weight ratios of the ionic and non-ionic polymers (ionic:non-ionic) can range from about 1:10 to about 10:1, preferably from about 1:5 to about 5:1. In preferred embodiments, the weight ratio is greater than 1:1, for example, from about 2 to about 5. In a particularly preferred embodiment, the ionic polymer is carboxymethycellulose, the non-ionic polymer is hydroxyethylcellulose, and the weight ratio (ionic:nonionic) is about 3:1.
  • In a preferred embodiment of the method of the invention, which results in the formation of superabsorbent polymer hydrogels having a particularly high swelling ratio (SR), the total precursor concentration in the aqueous solution is of at least 2% by weight referred to the weight of the water of the starting aqueous solution, and the amount of the cross-linking agent is between about 1% and about 5% by weight referred to the weight of the precursor. In the present description, the term “precursor” indicates the hydrophilic polymer(s) used as the precursors for the formation of the polymer hydrogel polymer network, for example, in certain embodiments the “weight of the precursor” is the weight of CMCNa used or the combined weights of CMCNa and HEC used. The aqueous solution preferably includes sorbitol in an amount of about 4% by weight relative to the weight of water.
  • The swelling ratio (SR) is a measure of the ability of the polymer hydrogel to absorb water. SR is obtained through swelling measurements at the equilibrium (using, for example, a Sartorius micro scale with a sensitivity of 10−5) and it is calculated with the following formula:

  • SR=(W s −W d)/W d
  • wherein Ws is the weight of the polymer hydrogel after immersion in distilled water for 24 hours, and Wd is the weight of the polymer hydrogel before immersion, the polymer hydrogel having been previously dried in order to remove any residual water.
  • According to the preparation method of the invention, in this embodiment, the cross-linking reaction is preferably carried out at a temperature between about 60° C. and 120° C. Varying the temperature during this stage of the process will enable one to increase or decrease the cross-linking degree of the polymer network. A cross-linking temperature of about 80° C. is preferred.
  • One particularly preferred embodiment of the method of the invention comprises the following steps: Step 1, the hydrophilic polymer(s), the carboxylic acid and, optionally, the molecular spacer are dissolved in water at room temperature; Step 2, the water is removed from the solution at 40° C. over a two-day period; Step 3, the product of Step 2 is heated to 80° C. for 10 hours to induce the cross-linking reaction and form a polymer hydrogel; Step 4, the polymer hydrogel is washed three times with water over 24 hours; Step 5, the washed polymer hydrogel is immersed in acetone for 24 hours to remove water; Step 6, the polymer hydrogel is further dried in an oven at 45° C. for 5 hours; and Step 7, the dried polymer hydrogel is milled to provide polymer hydrogel particles.
  • The present invention also provides polymer hydrogels which can be prepared using the methods of the invention. Such polymer hydrogels comprise a hydrophilic polymer cross-linked with a polycarboxylic acid. In other embodiments, the polymer hydrogels of the invention include at least two hydrophilic polymers cross-linked by a polycarboxylic acid. In one preferred embodiment, the polymer hydrogel comprises an ionic polymer and a non-ionic polymer and a polycarboxylic acid, preferably a C4 to C12-dicarboxylic acid, a tricarboxylic acid or a tetracarboxylic acid, where the polycarboxylic acid cross-links the ionic polymer and the non-ionic polymer. The weight ratio of ionic polymer to non-ionic polymer is preferably from about 1:5 to about 5:1, more preferably from about 2:1 to about 5:1, and most preferably about 3:1. In one particularly preferred embodiment, the ionic polymer is carboxymethylcellulose, the non-ionic polymer is hydroxyethylcellulose and the polycarboxylic acid is citric acid. In another preferred embodiment, the polymer hydrogel comprises an ionic polymer, for example, an anionic polymer or a cationic polymer. More preferably, the ionic polymer is carboxymethylcellulose or a salt thereof, such as sodium carboxymethylcellulose. In another particularly preferred embodiment, the polymer hydrogel comprises carboxymethylcellulose cross-linked with citric acid.
  • The polymer hydrogels of the invention have swelling ratios of at least about 5. Preferably, the polymer hydrogels of the invention are superabsorbent polymer hydrogels, for example, polymer hydrogels having an SR of at least 10. In preferred embodiments, the polymer hydrogels of the invention have SRs at least about 20, about 30, about 40, about 50, about 60, about 70, about 80, about 90 or about 100. For example, in certain embodiments, the polymer hydrogels of the invention have SRs from about 10 to about 100, from about 20 to about 100, from about 30 to about 100, from about 40 to about 100, from about 50 to about 100, from about 60 to about 100, from about 70 to about 100, from about 80 to about 100, or from about 90 to about 100. In certain embodiments, the invention includes polymer hydrogels having SRs up to 150, 200, 250, 300, 330 or 350.
  • In certain embodiments, the polymer hydrogels of the invention can absorb an amount of one or more bodily fluids, such as blood, blood plasma, urine, intestinal fluid or gastric fluid, which is at least 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 times their dry weight. The ability of the polymer hydrogel to absorb bodily fluids can be tested using conventional means, including testing with samples of bodily fluids obtained from one or more subjects or with simulated bodily fluids, such as simulated urine or gastric fluid. In certain preferred embodiments, the polymer hydrogels can absorb significant amounts of a fluid prepared by combining one volume of simulated gastric fluid (SGF) with eight volumes of water. SGF can be prepared using USP Test Solutions procedures which are known in the art. In some embodiments, the polymer hydrogels of the invention can absorb at least about 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 or more times their dry weight of this SGF/water mixture.
  • The polymer hydrogels of the invention include cross-linked polymers having varying extents of hydration. For example, the polymer hydrogels can be provided in a state of hydration ranging from a substantially dry or anhydrous state, such as a state in which from about 0% to about 5% of the polymer hydrogel by weight is water or an aqueous fluid, to states comprising a substantial amount of water or aqueous fluid, including up to a state in which the polymer hydrogel has absorbed a maximum amount of water or an aqueous fluid.
  • The polymer hydrogels of the invention can be used in methods for treating obesity, reducing food or calorie intake or achieving or maintaining satiety. The methods comprise the step of administering an effective amount of a polymer hydrogel of the invention to the stomach of a subject, preferably by causing the subject, such as a mammal, including a human, to ingest the polymer hydrogel. Such polymer hydrogels can be used to take up stomach volume, for example, by increasing the volume of a food bolus without adding to the calorie content of the food. The polymer hydrogel can be ingested by the subject prior to eating or in combination with food, for example, as a mixture of the polymer hydrogel with food. Upon ingestion and contact with gastric fluid or a combination of gastric fluid and water, the polymer hydrogel will swell. The polymer hydrogel can be ingested alone or in a mixture with liquid or dry food in a dry, partially swollen or fully swollen state, but is preferably ingested in a state of hydration which is significantly below its fluid capacity, more preferably the polymer hydrogel is ingested in an anhydrous state. Thus, the volume of the stomach taken up by the polymer hydrogel can be significantly greater than the volume of the polymer hydrogel ingested by the subject. The polymer hydrogels of the invention can also take up volume and/or exert pressure on the wall of the small intestine by moving from the stomach into the small intestine and swelling. Preferably, the polymer hydrogel will remain swollen in the small intestine for a period of time sufficient to inhibit the intake of food by the subject, before shrinking sufficiently for excretion from the body. The time sufficient to inhibit the intake of food by the subject will generally be the time required for the subject to eat and for the ingested food to pass through the small intestine, Such shrinking can occur, for example, by degradation through loss of cross-links, releasing fluid and decreasing in volume sufficiently for excretion from the body. Preferred polymers for use in this method exhibit pH-dependent swelling, with greater swelling observed at higher pH than at lower pH. Thus, such a polymer will not swell significantly in the stomach unless food and/or water is present to raise the pH of the stomach contents and will move into the small intestine. When ingested with food, the polymer hydrogel will initially swell in the stomach, then shrink when the stomach is emptied of food and the pH drops and then move from the stomach to the small intestine. In the higher pH environment of the small intestine the polymer hydrogel will swell, taking up volume in the small intestine and/or exerting pressure on the wall of the small intestine.
  • The polymer hydrogel can optionally be administered in combination with a pH modifying agent, which is an agent which alters the pH of the microenvironment of the polymer hydrogel, thereby modifying its ability to absorb fluids. For example, for polymer hydrogels comprising an anionic polymer, agents which increase the pH of the microenvironment can increase the swellability of the polymer hydrogel. Suitable pH modifying agents for use with the polymer hydrogels of the invention include buffering agents, H2 blockers, proton pump inhibitors, anatacids, proteins, nutritional shakes, and combinations thereof. Suitable buffering agents and antacids include ammonium bicarbonate, sodium bicarbonate, calcium carbonate, calcium hydroxide, aluminium hydroxide, aluminium carbonate, magnesium carbonate, magnesium hydroxide, potassium bicarbonate, potassium carbonate, potassium hydroxide, sodium carbonate, sodium hydroxide and combinations thereof. Suitable H2 blockers include cimetidine, ranitidine, famotidine, nizatidine and combinations thereof. Suitable proton pump inhibitors include omeprazole, lansoprazole, esorneprazole, pantoprazole, abeprazole, and combinations thereof.
  • The present polymer hydrogels can also be used for removing water from the gastrointestinal tract, for example, as a treatment for subjects suffering from kidney disease, including chronic and acute kidney disease, particularly subjects undergoing kidney dialysis. The polymer hydrogels can further be used to modify the fluid content in the gastrointestinal tract of a subject in need thereof, for example, for the treatment of constipation.
  • The invention further includes articles of manufacture which comprise the polymer hydrogels of the invention. Such articles of manufacture include articles in which polyacrylic polymer hydrogels are conventionally used, in consumer products, such as for example absorbent products for personal care (i.e., babies' napkins, sanitary towels, etc.) and in products for agriculture (e.g., devices for the controlled release of water and nutrients). The absorption properties of the polymer hydrogels of the invention, which in some embodiments depend on the amount of carboxymethylcellulose employed and which can be improved by the induction of a microporosity in the gel structure, are comparable to those of polyacrylic gels. The polymer hydrogels obtainable by the method of the present invention therefore possess mechanical properties which make them suitable for use in all of the above-mentioned fields. The present polymer hydrogels, however, have advantages over acrylic polymer hydrogels, such as biodegradability, the absence of any toxic by-products during the manufacturing process and the use of fewer and readily available reagents. Such features enable a real employment of the polymer hydrogels of the invention in the biomedical and pharmaceutical fields as well.
  • Thus, the scope of the present invention also includes the use of the polymer hydrogels obtainable by the method of the invention as an absorbent material in products which are capable of absorbing water and/or aqueous solutions and/or which are capable of swelling when brought into contact with water and/or an aqueous solution.
  • The polymer hydrogels and superabsorbent polymer hydrogels of the present invention may be used as absorbent materials in the following fields, which are provided by way of non-limiting example:
  • dietary supplements (for example, as the bulking agents in dietary supplements for hypocaloric diets capable of conferring a sensation of lasting satiety being retained into the stomach for a limited period of time, or as water and low molecular weight compounds supplements, such as mineral salts or vitamins, to be included into drinks in a dry or swollen form);
  • in agricultural products (for example, in devices for the controlled release of water and/or nutrients and/or phytochemicals, particularly for cultivation in arid, deserted areas and in all cases where it is not possible to carry out frequent irrigation; such products, mixed in a dry form with the soil in the areas surrounding the plant roots, absorb water during irrigation and are capable of retaining it, releasing it slowly in certain cases, together with the nutrients and phytochemicals useful for cultivation);
  • in personal hygiene and household absorbent products (such as for example, as the absorbent cores in babies'napkins, sanitary towels and the like);
  • in the field of toys and gadgets (such as for example in products which are capable of significantly changing their size once brought into contact with water or an aqueous solution);
  • in the biomedical field (for example, in biomedical and/or medical devices such as absorbent dressings for the treatment of highly exudative wounds, such as ulcers and/or burns, or in slow-release polymeric films suitable to slowly release liquids adapted for use in ophthalmology); and
  • in the body fluid management field, i.e., for controlling the amount of liquids into the organism, for example in products capable of promoting the elimination of fluids from the body, such as, for example, in the case of edema, CHF (chronic heart failure), dialysis.
  • The above-mentioned products, containing a polymer hydrogel of the present invention as the absorbent material, also fall within the scope of the invention.
  • The invention further includes the use of any of the polymer hydrogels of the invention in medicine. Such use includes the use of a polymer hydrogel in the preparation of a medicament for the treatment of obesity or any medical disorder or disease in which calorie restriction has a therapeutic, palliative or prophylactic benefit.
  • The following examples are provided to further illustrate the invention and are not to be construed as limiting its scope.
  • EXAMPLES
  • The materials and processes of the present invention will be better understood in connection with the following examples, which are intended as an illustration only and not limiting of the scope of the invention. Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art and such changes and modifications including, without limitation, those relating to the chemical structures, derivatives, formulations and/or methods of the invention may be made without departing from the spirit of the invention and the scope of the appended claims.
  • Example 1 Citric Acid Cross-Linking of Carboxymethylcellulose/Hydroxyethylcellulose Mixtures Materials
  • CMCNa (MW 700 kDa, DS 0.9, food grade), HEC (MW 250 kDa, food grade) were purchased from Eigenmann e Veronelli S.p.A. Milano and citric acid was supplied by Dal Cin S.p.A. Sesto San Giovanni Milano and used as received.
  • Polymer Hydrogel Synthesis
  • Polymer hydrogel samples were obtained by reacting, in water, CMCNa and HEC with citric acid as a cross-linking agent according the following procedure. First, a total polymer concentration of 2% by weight of water, using a mixture of CMCNa and HEC, with weight ratio equal to 3/1 was dissolved in distilled water by stirring gently at room temperature until a clear solution was obtained. Poor cross-linking efficiency has been reported if only CMCNa is used, due both to the electrostatic repulsion between polyelectrolyte chains and to the high degree of substitution of hydroxyl groups at C6, the 2.5 most reactive position [13]. CMCNa dissolution is slow at the concentration adopted; thus, first HEC was added to water till, after 5 min, a clear solution was obtained with a slight increase of viscosity; then, CMCNa was added, and the stirring was kept on till a clear solution was obtained (24 h), with a significant increase of viscosity. Finally, CA was added at different concentrations (1.75%, 2.75%, 3.75%, 10% and 20% w/w polymer) in order to obtain samples with various degrees of cross-linking. This final solution was used to mold 10 mm thick samples. All samples were first pre-dried at 30° C. for 24 h to remove absorbed water and then kept at 80° C. for the cross-linking reaction (24 h with intermediate control).
  • Moreover, samples containing neat HEC or neat CMCNa samples cross-linked with CA were also prepared following exactly the same experimental conditions used for HEC/CMCNa mixtures.
  • All samples were analyzed by FT IR measurements Anhydride formation was detected by monitoring its characteristic stretching band in the carbonyl region at 1738 cm−1 [14].
  • Swelling Ratio
  • Equilibrium swelling measurements for all the samples were carried out in distilled water using a Sartorius microbalance (10−5 sensitivity). The swelling ratio was measured by weighing samples before and after their immersion in distilled water for about 24 h. The swelling ratio (SR) is defined as following:

  • SR=(W s −W d)/W d
  • where Ws is the weight of the swollen polymer hydrogel and Wd is the weight of the dried sample [15].
    Differential Scanning calorimeter
  • A differential scanning calorimeter (Mettler-Toledo 822e Mettler DSC) was used for thermal analysis. The scanning temperature range and the heating rate were 10-200° C. and 5° C./min, respectively.
  • The adopted thermal cycle was: (1) heating 10-100° C.; (2) isotherm at 100° C. for 3 minutes; (3) cooling from 100° C. to 10° C.; (4) heating from 10° C. to 200° C.; (5) isotherm at 200° C.; (6) cooling until room temperature. An empty pan was used as a reference.
  • Fourier Transformed Infrared Spectroscopy
  • All FT IR spectra were recorded on a JASCO FT IR 660 plus spectrometer equipped with an attenuated total reflectance (ATR) crystal sampler. Film samples were used directly on a ATR crystal sampler at a resolution of 4 cm−1, by 300 scans, at absorbance range from 4000 cm−1 to 600 cm−1.
  • Results and Discussion
  • A DSC thermogram of neat citric acid showed a peak at about 60° C., attributable to a water loss process associated with the dehydration leading to an anhydride. A complete degradation, starting at about 160° C., is observed in the second scan.
  • DSC analysis of neat CMCNa and HEC powders indicates that some water is still absorbed in the polymers. Above 100° C. a possible degradation peak of CMCNa is detected. Both CMCNa and HEC show a thermal stability below 100° C.
  • A film of polymer hydrogel obtained using a 3:1 ratio of CMCNa/HEC and 3.75% by weight of polymer of citric acid was analyzed by DSC after drying the sample at 30° C. for 24 h and then reduced to powder. A large endothermic peak associated to the evaporation of the water produced by the anhydrification process is evident. A small exothermic peak, attributed to esterification is superimposed on the first one. In the second heating cycle the glass transition (Tg=38° C.) of the cross-linked cellulose mixture is observed.
  • After this preliminary DSC study, different polymer hydrogel samples were prepared according the following procedures. After mixing reagents in water, the reaction vessel was kept at 30° C. for 24 h in dry conditions to remove water. Then temperature was raised above 60° C., according with the results of the first DSC analysis, in order to obtain the citric acid anhydride. Above this limiting temperature citric anhydride is available for the cross-linking reaction with cellulose OH groups. Different reaction conditions were attempted in order to optimize the synthetic procedure, such as temperature and CA concentration as summarized in Table 1. Two different reaction temperatures for the cross-linking process, 80° C. and 120° C., were attempted. However, either to prevent degradation risks or to limit the reaction rate a temperature of 80° C. was chosen. Moreover, very high concentrations (10% and 20% by weight) of CA were initially used in order to amplify the FT IR signals associated with each chemical reaction step. First neat CMCNa and HEC were cross-linked with CA in order to investigate its reactivity with each of the polymers.
  • TABLE 1
    citric acid concentration
    Reaction label Initial polymer (% w/w polymer)
    A10 CMCNa 10
    A20 CMCNa 20
    B10 HEC 10
    B20 HEC 20
    C10 CMCNa/HEC (3/1) 10
    C20 CMCNa/HEC (3/1) 20
  • FT IR spectra were recorded of citric acid, of the A10 reaction mixture before heating and of the A10 reaction mixture after 5 h of heating. In the CA spectrum it is possible to observe a strong C═O band centred at 1715 cm−1 due to carboxylic acid. The FT IR spectrum of sample A10 shows a strong absorption band at 1590 cm−1 characteristic of cellulose [16]. After heating, the absorbance band at about 1590 cm−1 is still observed and additionally a new band at 1738 cm−1 appears Anhydrides display two stretching bands in the carbonyl region around 1758 cm−1 and 1828 cm−1. The higher frequency band is the more intense in acyclic anhydrides whereas cyclic anhydrides show the lower frequency C═O stretching band stronger than the stretching band at higher frequency [14]. The new peak observed at 1738 cm−1 can be attributed to the characteristic stretching band of the carbonyl group at lower frequency related to anhydride formation, an intermediate reaction necessary for reaction of CA with cellulose hydroxyl groups. In contrast, the carbonyl peak expected at higher frequency is not detectable probably due to its weak intensity.
  • FT IR spectra were recorded of citric acid, B10 reaction mixture before heating and B10 reaction mixture after 6.5 h of heating. The HEC spectrum again shows the band at 1590 cm−1 before and after heating while the absorbance of the carbonyl group at 1738 cm−1 appears only after heating at 80° C. as observed for the sample A10.
  • Although FT IR analysis is generally considered a qualitative technique, a literature study in literature carried out by Coma and co-workers demonstrated that infrared spectroscopy could be used at first approximation for the determination of the cross-linking rate in cross-linked cellulosic derivatives [9]. Starting from this consideration, the evolution of the different reactions finally leading to cross-linking at 80° C. was monitored by recording FT IR spectra at different reaction times.
  • The area under the absorbance peak at 1738 cm−1 (A1) representative of the carbonyl group, was compared with the area under the reference absorbance peak at 1592 cm−1 (A2) which is invariant in all spectra. The evolution of the anhydride was evaluated as the ratio of A1/A2 as a function of the reaction time. FTIR spectra of CMCNa polymer when the reaction is performed at 80° C. with 20% CA or 10% CA both show a similar trend: the anhydride band, that is absent before heating, reaches a maximum almost immediately after the first hour, successively decreases to a minimum after 3 h, then increasing again reaching a second maximum after 5 h. Finally a slower process reduces the band area to zero after 24 h. It is worth noting that in the spectrum of the 20% CA reaction, the second maximum matches a value (A1/A2=0.10) higher than those observed in the 10% CA reaction (A1/A2=0.04).
  • It is assumed that the peak at around 1738 cm−1 is due to the anhydrification process involving free CA followed by the first condensation of this anhydride with cellulose OH leading to a fast disappearance of the anhydride C═O groups. Then the carboxylate groups now linked to the polymer are able to form again an anhydride leading to an increase of the 1738 cm−1 peak. The second reaction of this anhydride is responsible for the cross-linking, results in a new anhydride group consumption and consequent reduction of the peak at 1738 cm−1. This second reaction is slower since it involves groups linked to large macromolecules and hence is more sterically hindered, as has also been reported for other cellulose cross-linking processes [17]. This possible reaction mechanism is confirmed by the swelling measurements.
  • FTIR spectra were also recorded for reactions of HEC polymer when the reaction is performed at 80° C. with either 20% CA or 10% CA. In the 10% CA case, the anhydride band intensity increases from 0 to 0.098 when the reaction time increase from 0 h to 6.5 h, but drops to 0 when the reaction time reaches 24 h. The 20% CA reaction follows exactly the same trend providing a maximum value of 0.079 at 5 h. Assuming that the cross-linking mechanism is the same as described for CMCNa, the anhydrification and esterification reactions appear superimposed in this case. Therefore, in the FTIR spectra, the HEC polymer shows a single peak. This latter result was in accordance with conclusion of Xie and co-workers [18]. They studied the degree of substitution, as evaluation of cross-linking esterification, on starch thermally reacted with CA at different reaction time and found a maximum after a few hours.
  • To explain the data observed in all FTIR spectra recorded after 24 hours, we supposed that in all cases the polymer is unstable when is kept in the oven for 24 hours because of unidentified secondary reactions take place modifying polymer structure that involve also ester functions. Xie and co-workers [18] work guessed that the degree of substitution reached a maximum and then decreased since dissociation of the substituents from starch occurred when the reaction time was longer than 7 h.
  • Finally, to complete this study, polymer mixtures of CMCNa and HEC were cross-linked. CMCNa has carboxylic acid functional groups in its structure that increase the volume variation process in solution. A preliminary attempt to follow the reaction pathway failed. Probably the reaction systems considered are too complex having many different reaction centers. FT IR spectra of C10 reaction registered before, after 8 h and after 13 h of heating were compared. Reaction sample C20 shows similar spectra. Moreover, it is worth noting that when polymer mixtures are used (C10 and C20) a broad signal appears at about 1715 cm−1, especially when a higher CA concentration is used in the reaction. In fact, with 20% of CA the signal of CA at 1715 cm−1 is very broad and overlapped to the polymer signal at 1590 cm−1 then a clear band is not detectable. However, it should be pointed out a band around 1715 cm−1 before heating. The C10 reaction mixture before heating shows a band around 1715 cm−1 covering the absorbance region monitored previously for the other reactions (A10, A20, B10, B20); consequently a clear assignment to the carbonyl group is difficult. However, the other two spectra indicate that this band moves to higher wavenumbers during the cross-linking reaction. In particular after 8 h, the FT IR spectrum shows a broad band in the range of 1711 cm−1-1736 cm−1 and after 13 h this band appears more clearly as a narrow absorbance band at 1737 cm−1, which is typical of carbonyl groups. Spectra of C20 reaction provide similar results. Although a quantitative analysis of carbonyl groups is not possible when C10 and C20 samples are cross-linked, an evaluation of the carbonyl peak similar to those observed for the reaction of the neat polymers can be assumed.
  • The cross-linking kinetics were also monitored studying the swelling behaviour during the reaction progress. Swelling ratio was calculated as a function of the reaction time for: (a) CMCNa with 10% or 20% of CA concentration; (b) HEC with 10% or 20% of CA concentration; (c) the mixture of CMCNa and HEC (3/1) with 10% or 20% CA concentration; (d) the mixture of CMCNa and HEC (3/1) with 1.75%, 2.75% or 3.75% CA concentration.
  • The results obtained indicate that the swelling of CMCNa cross-linked with 10% of citric acid is higher than HEC with the same citric acid concentration after 24 h. When 20% of citric acid was added to the celluloses, the shape of the swelling curves are similar for HEC and CMCNa. In this case, as cross-linking proceeds the swelling of HEC based samples decreases faster than CMCNa samples indicating that a higher rate of reaction between CA and HEC. This probably occurs because HEC is less sterically hindered than CMCNa and can react more quickly than CMCNa chains. In addition in each repeating unit, HEC has more OH groups than CMCNa (3 vs 2).
  • The maximum swelling of CMCNa/CA sample is observed at the gelation onset, after 3 h, when the second esterification reaction, those leading to cross-linking, begins. Then as the cross-linking process increases the corresponding equilibrium water sorption decreases, confirming the results of FTIR analysis.
  • The same reaction mechanism can be assumed for neat HEC cross-linked with CA. However in this case the overall behaviour is slightly different as a consequence of the absence of carboxylic groups bonded to the polymer. The results of swelling experiments must be interpreted taking into account that the CA introduces the high hydrophilic carboxylic groups that are responsible of the formation of a polyelectrolyte network. Therefore the water sorption is significantly increased as carboxylic groups are linked first to the HEC chains and then to the gelled network. This effect cannot be appreciated in CMCNa polymer hydrogels since a large amount of —COOH groups, those linked to the CMCNa chains, is already bonded to the network at the onset of gelation. A similar trend is observed for the mixtures of HEC and CMCNa.
  • Polymer hydrogels of practical use presenting a high degree of swelling were obtained with a reduced concentration of citric acid (1.75%, 2.75%, 3.75% by weight of polymer). With a citric acid concentration of 3.75% the swelling ratio can reach 900. This polymer hydrogel, after swelling, is characterized by adequate stiffness and it is able to keep the same shape of the synthesis vat. Polymer hydrogels formerly synthesized [13] using divinyl sulfone, a toxic reagent, as cross-linking agents and the same ratio between CMCNa and HEC were characterized by a maximum swelling ratio of 200. In this case a higher swelling ratio is obtained using an environmentally friendly cross-linking agent. At concentrations lower than 1.75% CA, a weak cross-linking associated with insufficient mechanical property is observed.
  • Conclusions
  • This work shows for the first time that CA can be successfully used as cross-linking agent of CMCNa/HEC mixtures. As shown in FIG. 1, an esterification mechanism based on an anhydride intermediate formation is proposed to explain the reaction of cellulose polymers with CA.
  • The cross-linking reaction for CMCNa/HEC system was observed either by DSC or by FTIR analysis. The evolution of the different cross-linking reactions was monitored by means of FT IR spectra collected at different reaction times using an excess of citric acid. The swelling ratio, monitored at different reaction times, confirmed the reaction path figured out from FTIR analysis. An optimal degree of swelling (900) for practical applications was achieved using low CA concentrations. The polymer hydrogel obtained through the method described in this Example 1 has the great advantage to reduce primary and production costs and avoid any toxic intermediate during its synthetic process.
  • Example 2 Citric Acid Cross-Linking of Carboxymethylcellulose and Carboxymethylcellulose/Hydroxyethylcellulose Mixtures in the Presence of Sorbitol Materials and Methods
  • All the materials employed were provided by Aldrich Italia and were used without any further modification. The devices used in the characterisation, in addition to the standard laboratory glassware, cupboards and counters for standard synthesis, were a scanning electron microscope (SEM) JEOL JSM-6500F, a precision 10−5 g Sartorius scale, an Isco mixer and an ARES rheometer.
  • The polymer hydrogels were prepared by cross-linking an aqueous solution of carboxymethylcellulose sodium salt (CMCNa) and hydroxyethylcellulose (HEC), using citric acid (CA) as the cross-linking agent and sorbitol as the molecular spacer. The composition of a gel is given by the nominal amount of the reagents in the starting solution. The parameters used to define said composition are the following:
  • (i) the precursor weight concentration (%)=the total mass of polymers in the solution (e.g. CMCNa+HEC) (g)×100/mass of water (g);
    (ii) the CMCNa to HEC weight ratio=mass of CMCNa (g) in the solution/mass of HEC in the solution (g);
    (iii) the cross-linking agent (CA) weight concentration (%)=mass of CA in the solution (g)×100/mass of the precursors in the solution (g); and
    (iv) the molecular spacer (e.g. sorbitol) weight concentration (%)=mass of molecular spacer (g)×100/mass of water (g).
  • The laboratory tests demonstrated that a polymer concentration lower than 2% and a CA concentration lower than 1% either do not achieve cross-linking of the gel or led to the synthesis of a gel having very poor mechanical properties. On the other hand, CA concentrations higher than about 5% significantly increase the cross-linking degree and polymer stabilization, but excessively reduce the absorption properties of the superabsorbent gel.
  • Since CMCNa is the ionic polymer species, it is possible to achieve the desired absorption properties adjusting the weight ratio of carboxymethylcellulose sodium salt (CMCNa) to hydroxyethylcellulose (HEC). A CMCNa/HEC weight ratio of between 0/1 and 5/1, preferably between 1/1 and 3/1, was observed to enable the synthesis of a polymer hydrogel having optimum absorption properties.
  • Examples relating to the synthesis of different polymer hydrogels according to the invention, differing from one another in the weight percent (wt %) of citric acid and in the composition of the polymeric precursor, are provided below.
  • Preparation of Polymer Hydrogel A:
  • in a beaker containing distilled water, sorbitol at a concentration of 4% by weight referred to the weight of distilled water was added and mixed until complete solubilisation, which occurred within a few minutes. The CMCNa and HEC polymers are added at a total concentration of 2% by weight referred to the weight of distilled water, with a CMCNa/HEC weight ratio of 3/1. Mixing proceeded until solubilisation of the whole quantity of polymer is achieved and the solution became clear. At this stage, citric acid at a concentration of 1% by weight referred to the weight of the precursor was added to the solution, whose viscosity had greatly increased. The solution thereby obtained was poured into a vessel and dried at 48° C. for 48 hours. During this process, the macromolecules are stabilised into a polymeric network which is the backbone of the polymer hydrogel. At the end of the cross-linking process, the polymer hydrogel was washed with distilled water for 24 hours at room temperature. During this phase, the polymer hydrogel swelled up thereby eliminating the impurities. In order to obtain the maximum swelling degree and elimination of all of the impurities, at least 3 rinses with distilled water were performed during the 24 hours washing step. At the end of this washing step, the polymer hydrogel was dried by phase inversion in acetone as the nonsolvent, until a glassy white precipitate is obtained. The precipitate is then placed into an oven at 45° C. for about 3 hours, to remove any residual trace of acetone.
  • Preparation of Polymer Hydrogel B:
  • Polymer hydrogel B was prepared as polymer hydrogel A, with the only exception that the polymer is made only of CMCNa, and that the CMCNa concentration is 2% by weight referred to the weight of distilled water.
  • Preparation of Polymer Hydrogel C:
  • Polymer hydrogel C was prepared as polymer hydrogel B, with the only exception that the citric acid concentration is 2% by weight referred to the weight of CMCNa.
  • Preparation of Polymer Hydrogel D:
  • Polymer hydrogel D was prepared as polymer hydrogel B, with the only exception that the citric acid concentration is 0.5% by weight referred to the weight of CMCNa.
  • Absorption Measurements
  • In order to test the absorption properties of the polymer hydrogels prepared as described above, they were subjected to absorption measurements in distilled water. The absorption measurements essentially consist of placing the dry sample, obtained from the drying step, in distilled water, so that it swells up until an equilibrium condition is reached.
  • The absorption properties of the gel are assessed based on its swelling ratio (SR), defined according to the formula illustrated above. In order to minimise the influence of experimental errors, each test was performed on three samples from each gel, and then the mean value of the results of the three measurements was taken as the effective value.
  • Three dry samples were taken from each of the test gels, each having different weights and sizes. After recording the weights, the samples were swollen in abundant quantities of distilled water at room temperature. Upon reaching equilibrium after 24 hours, the samples were weighed once more in order to determine the swelling ratio.
  • Results
  • Table 2 below reports some of the results obtained, in terms of the swelling ratio, varying the concentrations of the reagents and the cross-linking times (6 hours, 13 hours, 18 hours, 24 hours).
  • TABLE 2
    Sam- sorbi- cross-linking time/swelling ratio
    ple CMCNa HEC CA tol 6 13 18 24
    75% 25% hours hours hours hours
    g16 2% 1% 4% nr 50 30 20
    g17 4% 1% 4% nr 25 10 5
    nr = not cross-linked
  • It is pointed out that the increase in the polymer concentration exerts a negative effect on the swelling properties of the final product and it is also pointed out that the cross-linking time exerts a significant effect of the absorbing properties.
  • Thus, further experiments were carried out maintaining the polymer concentration fixed at 2% and varying the citric acid concentration. The results are reported in Table 3.
  • TABLE 3
    Sam- sorbi- cross-linking time/swelling ratio
    ple CMCNa HEC CA tol 6 13 18 24
    75% 25% hours hours hours hours
    g21 2% 2% 4% 40 25 20 10
    g22 2% 1% 4% nr 50 30 20
    g23 2% 0.5% 4% nr Nr 50 30
    nr = not cross-linked
  • Table 3 shows that the sample having the best swelling ratio is the sample designated as g22, which is characterised by a citric acid (CA) concentration of 1%.
  • Thus, further experiments were performed removing completely HEC from the solution. This should render the polymer hydrogel more hydrophilic thereby leading to an increase of the swelling ratio. Table 4 shows some of the results obtained.
  • TABLE 4
    sorbi- cross-linking time/swelling ratio
    Sam- CMCNa HEC CA tol 6 13 18 24
    ple 100% 0% hours hours hours hours
    g30 2% 2% 4% nr 85 55 30
    g31 2% 1% 4% nr 100 75 40
    g32 2% 0.5% 4% nr Nr 70 50
    nr = not cross-linked

    The highest swelling ratio is associated with a cross-linking time of 13 hours and a citric acid concentration of 1%. It is also to be noticed that higher citric acid concentrations together with shorter cross-linking times lead to equally satisfactory swelling ratios, although the reaction is very fast and less easy to control.
  • Finally, the possibility of increasing the swelling ratio by creating porosity into the material which could promote the absorbing properties, was evaluated. For that purpose, the sample g31, subjected to cross-linking for 12 hours, was swelled into distilled water for 24 hours and then dried by phase inversion in acetone. With this technique, a swelling ratio of 200 was obtained.
  • Example 3 Swelling of a Polymer Hydrogel in Simulated Gastric Fluid (SGF) and SGF/Water Mixtures
  • This example describes an evaluation of the superabsorbent polymer hydrogel denoted polymer hydrogel B in Example 2 in in vitro swelling and collapsing experiments in various media at 37° C.
  • Swelling Kinetics (in 100% SGF) at 37° C.
  • 100 mg of the dried polymer hydrogel was immersed in either simulated gastric fluid (“SGF”) or a mixture of SGF and water and allowed to swell until an equilibrium condition was reached. SGF was prepared according to USP Test Solutions procedures. The swelling ratio in each fluid was determined at various time points. The results are set forth in Tables 5 and 6.
  • TABLE 5
    Swelling of dry polymer hydrogel B in 100% SGF at 37° C.
    The weights were recorded at 15, 30, 60 and 90 min.
    Swelling
    Time, min Swelling Ratio, g/g
    15 15.4
    30 15.6
    60 16.2
    90 15.1
  • TABLE 6
    Swelling of Dry Polymer hydrogel B in a mixture of SGF and Water
    (1:8) at 37° C. The weights were recorded at 15, 30, 60 and 90 min.
    Sweling Swelling
    Time, min Ratio, g/g
    15 78.8
    30 84.6
    60 88.6
    90 79.3

    Collapsing Kinetics (with Addition of SGF) at 37° C.
  • To simulate the effect of digestion on a hydrated polymer hydrogel, to the swollen polymer hydrogel from above (Table 6, SGF/water) after 60 minutes, 100% SGF was slowly added to collapse the gel particles. Swelling ratio was monitored as a function of cumulative volume of added SGF. The results are set forth in Table 7.
  • TABLE 7
    SGF added (mL) Swelling Ratio (g/g)
    0 88.6
    8 23.1
    30 22.6
    50 23.1
    75 17.1
  • Kinetics of Swelling (in 1:8 SGF/Water), Collapsing (in SGF) and Re-Swelling (in Simulated Intestinal Fluid)
  • Experiments were conducted by monitoring the swelling ratio through a full cycle of swelling in 1:8 SGF/water, collapsing in SGF, and re-swelling (then degradation) in simulated intestinal fluid (SIF), all at 37° C. Experiments performed and results are provided in Table 8, for the re-swelling/degradation kinetics. pH values are given when available.
  • TABLE 8
    Kinetics of swelling in SGF/water, collapsing
    in SGF, and re-swelling in SIF
    60-min Collapse
    Swell in in 70-mL Re-swelling/Degradation in SIF
    Expt. SGF/water SGF 30 45 90 120
    # Swell Ratio Swell Ratio min min min min
    1 95.5 20.7 71.2 87.3
    pH 4.82 pH 1.76
    2 95.3 19.5 72.6 80.5
    pH 1.75
  • Conclusions:
  • This polymer hydrogel swells in simulated gastric fluids (pH 1.5) approximately 15 fold, and in a simulated gastric fluids/water mixture (pH 3) approximately 85 fold. This indicates that the polymer hydrogel has a pH/swelling correlation where at pH below 3 (pKa of CMC is ˜3.1) there will be limited swelling of the polymer hydrogel due to absence of the Donnan effect. The polymer can also swell in the increased pH of simulated intestinal fluid.
  • Example 4 Effect of Polymer Hydrogel on Rat Feeding Behavior
  • A series of experiments was conducted to assess the effect of polymer hydrogel B in laboratory animals. One objective of these studies was to determine the effect of polymer hydrogel B on food intake in rats. The study was conducted in male Sprague Dawley rats, by acute administration of pre-swollen polymer hydrogel B by oral gavage
  • A total of 22 male Sprague-Dawley rats were randomized into two weight-matched groups prior to polymer hydrogel or vehicle administration (the polymer hydrogel B was pre-swollen in water, 100 mg in 10 mL water). Food and water intake (digital balance) as well as locomotor activity (consecutive beam brakes) were monitored online every 5 minutes for 40 hours post dosing. Food and water intake data were collected using MaNi FeedWin, an online computerized feeding system using digital weighing cells. Two types of baseline food intake (digital balance) and lick counts were monitored. All data was entered into Excel spread-sheets and subsequently subjected to relevant statistical analyses Results are presented as mean±SEM unless otherwise stated. Statistical evaluation of the data is carried out using one-way or two-way analysis of variance (ANOVA).
  • Results and Conclusions
  • FIG. 2, a graph of cumulative food intake as a function of time, represents a typical study result. There was no difference between the groups at base line. Gavage of 8 mL of polymer hydrogel B induced satiety in the rats that led to a significnt decrease in food intake. As shown in the yellow line, this polymer hydrogel induced a marked decrease in food intake that persisted over 2 hours. These data suggest that polymer hydrogel B can induce satiety in animals and leads to a decrease in food intake.
  • While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
  • REFERENCES
    • [1] Anbergen U, Opperman W, Polymer, 31, 1854 (1990).
    • [2] Esposito F et al., J Appl Polym Sci, 60, 2403 (1996).
    • [3] Denn W L, Ferguson G N, U.S. Pat. No. 3,589,364, 1971.
    • [4] Sachetto J P et al., ES 484964, 1978.
    • [5] Choi Y S et al., Biomaterials, 20, 409 (1999).
    • [6] International patent application WO 2006/070337.
    • [7] Glusker J P. Acc. Chem. Res. 1980; 13:345-352.
    • [8] Wang C C et al., Applied Catalysis A: General 2005; 293:171-179.
    • [9] Coma V et al., Carbohydrate Polymers 2003; 51:265-271.
    • [10] Xie X S et al., Food Research International 2006; 39:332-341.
    • [11] Yang C Q et al., J. Appl. Polym. Sci. 1998; 70:2711-2718.
    • [12] Flory P. J., Principles of Polymer Chemistry, Ithaca, N.Y.: Cornell University Press, 1953.
    • [13] Sannino A. et al., Polymer 2005; 46:4676.
    • [14] Silverstein R. M., et al. Spectrometric Identification of Organic Compounds, Wiley, 1991, pp 120-130.
    • [15] Peppas N A, Polymer hydrogels in Medicine and Pharmacy; CRC Press, Boca Raton, Fla., 1987, p. 29.
    • [16] Chen C C and Wang C C, J. Sol-Gel Sci. Technol. 2006, 40: 31.
    • [17] Xie X S and Liu Q, Starch 2004, 56:364.
    • [18] Khutoyanskaya O V et al., Macromol. Chem. Phys. 2005, 206:1497.

Claims (19)

1-35. (canceled)
36. A polymer hydrogel comprising an ionic polymer and a polycarboxylic acid selected from C4-C12-dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids, wherein said polycarboxylic acid cross-links the ionic polymer, said polymer hydrogel having a swelling ratio in distilled water of at least about 50.
37. The polymer hydrogel of claim 36, wherein the ionic polymer is carboxymethylcellulose and the polycarboxylic acid is citric acid.
38. The polymer hydrogel of claim 37 wherein the weight ratio of citric acid to carboxymethylcellulose is about 1% to about 5%.
39. (canceled)
40. The polymer hydrogel of claim 36 having a swelling ratio in distilled water of at least 70.
41. The polymer hydrogel of claim 40 having a swelling ratio in distilled water of at least about 100.
42-51. (canceled)
52. The polymer hydrogel of claim 40 having a swelling ratio in distilled water of at least 80.
53. The polymer hydrogel of claim 40 having a swelling ratio in distilled water of about 50 to about 250.
54. The polymer hydrogel of claim 40 having a swelling ratio in distilled water of about 50 to about 350.
55. A pharmaceutical composition comprising the polymer hydrogel of claim 36.
56. The pharmaceutical composition of claim 55 wherein the ionic polymer is carboxymethylcellulose and the polycarboxylic acid is citric acid.
57. The pharmaceutical composition of claim 56 wherein the weight ratio of citric acid to carboxymethylcellulose is about 1% to about 5%.
58. The pharmaceutical composition of claim 55 wherein the polymer hydrogel has a swelling ratio in distilled water of at least about 70.
59. The pharmaceutical composition of claim 55 wherein polymer hydrogel has a swelling ratio in distilled water of at least about 100.
60. The pharmaceutical composition of claim 55 wherein the polymer hydrogel has a swelling ratio in distilled water of at least about 80.
61. The pharmaceutical composition of claim 55 wherein the polymer hydrogel has a swelling ratio in distilled water of about 50 to about 250.
62. The pharmaceutical composition of claim 55 wherein the polymer hydrogel has a swelling ratio in distilled water of about 50 to about 350.
US14/150,430 2007-08-10 2014-01-08 Polymer Hydrogels and Methods of Preparation Thereof Abandoned US20140296507A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US14/150,430 US20140296507A1 (en) 2007-08-10 2014-01-08 Polymer Hydrogels and Methods of Preparation Thereof
US15/185,443 US10086014B2 (en) 2007-08-10 2016-06-17 Polymer hydrogels and methods of preparation thereof
US16/546,722 US20200046755A1 (en) 2007-08-10 2019-08-21 Polymer hydrogels and methods of preparation thereof
US17/333,424 US20210353665A1 (en) 2007-08-10 2021-05-28 Polymer Hydrogels and Methods of Preparation Thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/IT2007/000584 WO2009022358A1 (en) 2007-08-10 2007-08-10 Superabsorbent polymer hydro gels and a method of preparing thereof
PCT/EP2008/006582 WO2009021701A2 (en) 2007-08-10 2008-08-08 Polymer hydrogels and methods of preparation thereof
US12/703,286 US8658147B2 (en) 2007-08-10 2010-02-10 Polymer hydrogels and methods of preparation thereof
US14/150,430 US20140296507A1 (en) 2007-08-10 2014-01-08 Polymer Hydrogels and Methods of Preparation Thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/703,286 Continuation US8658147B2 (en) 2007-08-10 2010-02-10 Polymer hydrogels and methods of preparation thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US15/185,443 Continuation US10086014B2 (en) 2007-08-10 2016-06-17 Polymer hydrogels and methods of preparation thereof
US16/546,722 Continuation US20200046755A1 (en) 2007-08-10 2019-08-21 Polymer hydrogels and methods of preparation thereof

Publications (1)

Publication Number Publication Date
US20140296507A1 true US20140296507A1 (en) 2014-10-02

Family

ID=39312966

Family Applications (5)

Application Number Title Priority Date Filing Date
US12/703,286 Active 2028-07-30 US8658147B2 (en) 2007-08-10 2010-02-10 Polymer hydrogels and methods of preparation thereof
US14/150,430 Abandoned US20140296507A1 (en) 2007-08-10 2014-01-08 Polymer Hydrogels and Methods of Preparation Thereof
US15/185,443 Active US10086014B2 (en) 2007-08-10 2016-06-17 Polymer hydrogels and methods of preparation thereof
US16/546,722 Abandoned US20200046755A1 (en) 2007-08-10 2019-08-21 Polymer hydrogels and methods of preparation thereof
US17/333,424 Abandoned US20210353665A1 (en) 2007-08-10 2021-05-28 Polymer Hydrogels and Methods of Preparation Thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/703,286 Active 2028-07-30 US8658147B2 (en) 2007-08-10 2010-02-10 Polymer hydrogels and methods of preparation thereof

Family Applications After (3)

Application Number Title Priority Date Filing Date
US15/185,443 Active US10086014B2 (en) 2007-08-10 2016-06-17 Polymer hydrogels and methods of preparation thereof
US16/546,722 Abandoned US20200046755A1 (en) 2007-08-10 2019-08-21 Polymer hydrogels and methods of preparation thereof
US17/333,424 Abandoned US20210353665A1 (en) 2007-08-10 2021-05-28 Polymer Hydrogels and Methods of Preparation Thereof

Country Status (18)

Country Link
US (5) US8658147B2 (en)
EP (5) EP2463308B1 (en)
JP (5) JP5485151B2 (en)
CN (2) CN101796075B (en)
AU (1) AU2008286354B2 (en)
CA (1) CA2695974C (en)
CY (2) CY1115978T1 (en)
DK (2) DK2532685T3 (en)
ES (3) ES2526905T3 (en)
HK (1) HK1172633A1 (en)
HR (1) HRP20150121T1 (en)
HU (2) HUE024121T2 (en)
MX (1) MX2010001629A (en)
PL (2) PL2463308T3 (en)
PT (2) PT2532685E (en)
RU (2) RU2493170C2 (en)
SI (2) SI2532685T1 (en)
WO (2) WO2009022358A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9353191B2 (en) 2011-06-07 2016-05-31 Gelesis Llc Method for producing hydrogels
WO2017136745A1 (en) 2016-02-05 2017-08-10 Entrega Inc. Oral dosage form with drying agent for delivery of active agent
WO2017180383A1 (en) * 2016-04-16 2017-10-19 Zymtronix, Llc Magnetic macroporous polymeric hybrid scaffolds for immobilizing bionanocatalysts
WO2017189422A1 (en) * 2016-04-25 2017-11-02 Gelesis, Llc. Method for treating constipation
US9855294B2 (en) 2014-06-20 2018-01-02 Gelesis, Llc Methods for treating overweight or obesity
US10179824B2 (en) 2015-01-29 2019-01-15 Gelesis Llc Method for producing hydrogels coupling high elastic modulus and absorbance
WO2019023060A3 (en) * 2017-07-28 2019-03-07 Kimberly-Clark Worldwide, Inc. Nanoporous superabsorbent particles
EP3517116A4 (en) * 2016-09-23 2019-10-23 Sullivan Barrera, Michael O., Jr. A cross-linked structure for tissue regeneration and engineering and the method for synthesising same
WO2020005229A1 (en) * 2018-06-27 2020-01-02 Kimberly-Clark Worldwide, Inc. Nanoporous superabsorbent particles
WO2020005230A1 (en) * 2018-06-27 2020-01-02 Kimberly-Clark Worldwide, Inc. Absorbent article containing nanoporous superabsorbent particles
US10792649B2 (en) 2015-07-15 2020-10-06 Zymtronix, Llc Automated bionanocatalyst production
US10881102B2 (en) 2015-05-18 2021-01-05 Zymtronix, Llc Magnetically immobilized microbiocidal enzymes
US10993436B2 (en) 2016-08-13 2021-05-04 Zymtronix Catalytic Systems, Inc. Magnetically immobilized biocidal enzymes and biocidal chemicals
US11931469B2 (en) 2018-07-20 2024-03-19 Kimberly-Clark Worldwide, Inc. Absorbent article having a reduced humidity level

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009022358A1 (en) * 2007-08-10 2009-02-19 Luigi Ambrosio Superabsorbent polymer hydro gels and a method of preparing thereof
CA2743559C (en) * 2008-11-18 2018-01-02 One S.R.I. Methods and compositions for weight management and for improving glycemic control, comprising cross-linked, edible polymer hydrogels
IT1393778B1 (en) 2009-04-06 2012-05-08 Sannino PROCEDURE FOR WASTE TREATMENT.
AU2011206908B2 (en) * 2010-01-13 2014-09-04 Georg Bischof Composition for producing a temporary intestinal occlusion
GB201000879D0 (en) * 2010-01-20 2010-03-10 Univ Reading The Improved hydrogel synthesis
CN101983974B (en) * 2010-10-08 2014-07-16 青岛聚大洋海藻工业有限公司 Extracting and processing technology of food additive G-type alginate
RU2455007C1 (en) * 2010-11-01 2012-07-10 Учреждение Белорусского государственного университета "Научно-исследовательский институт физико-химических проблем" Method for producing gel-forming dextrane phosphates
IT1404015B1 (en) * 2011-02-04 2013-11-08 Hsd Holding Smart Device S R L USE OF A DESTRANO POLYMER RETICULATED AS A FILTER AGAINST INHALATION OF HEALTH HARMFUL SUBSTANCES
JP6135896B2 (en) * 2011-03-25 2017-05-31 Jsr株式会社 Polymer gel and method for producing the same
WO2012148953A1 (en) * 2011-04-25 2012-11-01 Stc.Unm Solid compositions for pharmaceutical use
US9760009B2 (en) * 2011-05-13 2017-09-12 Clarkson University Cross-linked polymer based hydrogel material compositions, methods and applications
JP2013129612A (en) * 2011-12-20 2013-07-04 Kao Corp Medicine for sustaining feeling of fullness
KR101212504B1 (en) * 2012-06-21 2012-12-24 염다원 Antimicrobial hydrogel comprising coptis chinesis
US9145340B2 (en) 2012-08-13 2015-09-29 Verdesian Life Sciences, Llc Method of reducing atmospheric ammonia in livestock and poultry containment facilities
CN103724633A (en) * 2012-10-15 2014-04-16 中国科学院兰州化学物理研究所 Granular hydrogel
US9961922B2 (en) 2012-10-15 2018-05-08 Verdesian Life Sciences, Llc Animal feed and/or water amendments for lowering ammonia concentrations in animal excrement
RU2519927C1 (en) * 2013-01-18 2014-06-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Южно-Российский государственный университет экономики и сервиса" (ФГБОУ ВПО "ЮРГУЭС") Heat-removing clothing design
ITRM20130088A1 (en) * 2013-02-14 2014-08-15 Jaber Innovation S R L SUPER-ABSORBENT BIODEGRADABLE HYDROGELS
BR112015019577B1 (en) * 2013-04-12 2022-02-08 Nutrition & Biosciences Usa 1, Llc PROCESS FOR PREPARING AN AQUEOUS SOLUTION OF A METHYLCELLULOSE, AQUEOUS SOLUTION OF A PROTEIN-FREE METHYLCELLULOSE AND DRUG, FOOD, FOOD INGREDIENT OR FOOD SUPPLEMENT
US10512957B2 (en) 2013-08-02 2019-12-24 Regenesis Bioremediation Products Colloidal agents for aquifer and metals remediation
US9770743B2 (en) * 2013-08-02 2017-09-26 Regenesis Bioremediation Products Colloidal agents for aquifer remediation
US11254620B2 (en) 2013-08-05 2022-02-22 Verdesian Life Sciences U.S., Llc Micronutrient-enhanced polymeric seed coatings
TW201522390A (en) 2013-08-27 2015-06-16 特級肥料產品公司 Polyanionic polymers
CA2923561C (en) 2013-09-05 2022-05-03 Verdesian Life Sciences, Llc Polymer-boric acid compositions
JP6359670B2 (en) 2013-12-20 2018-07-18 リライアンス インダストリーズ リミテッドReliance Industries Ltd. Water-absorbing polymer and process for its preparation
WO2015097033A1 (en) * 2013-12-23 2015-07-02 Basf Se Polysaccharide hydrogels
CN103788217B (en) * 2013-12-26 2016-05-11 昆明理工大学 A kind of cellulose gel glue material, Preparation method and use
BR112016023522B1 (en) * 2014-04-10 2021-03-23 Basf Se COMPOSITION FOR ORAL CARE, POLYESTERAMIDE, COMPOUND, METHODS TO INHIBIT BACTERIAL PLATE IN THE ORAL CAVITY, TO SWEET A COMPOSITION FOR ORAL CARE AND TO THICKEN A COMPOSITION FOR ORAL CARE AND USE OF THE COMPOSITION FOR ORAL CARE
CN103962111B (en) * 2014-05-08 2016-02-17 闽江学院 Cationic water gel rubber material
CA2945823C (en) 2014-05-21 2022-04-26 Verdesian Life Sciences, Llc Polymer soil treatment compositions including humic acids
WO2015179552A1 (en) 2014-05-22 2015-11-26 Verdesian Life Sciences, Llc Polymeric compositions
WO2016201230A1 (en) 2015-06-10 2016-12-15 Rhodia Operations Phosphonated polysaccharides and gels and process for making same
EP3144340A1 (en) 2015-09-17 2017-03-22 Solvay Acetow GmbH Polymer gels, method of preparation and uses thereof
JP6407204B2 (en) * 2015-10-05 2018-10-17 ユニ・チャーム株式会社 Biodegradable water-absorbing agent and production method thereof
WO2017061166A1 (en) * 2015-10-05 2017-04-13 ユニ・チャーム株式会社 Biodegradable water absorbent and method for producing same
CN105860107B (en) * 2016-04-26 2018-02-09 中南大学 A kind of hydrogen peroxide response and the preparation method of the aquagel with electro-chemical activity
EP3490538A4 (en) 2016-08-01 2020-03-18 The Brigham and Women's Hospital, Inc. Particles for delivery of proteins and peptides
RU175482U1 (en) * 2016-08-04 2017-12-06 Федеральное государственное бюджетное учреждение науки Институт высокомолекулярных соединений Российской академии наук EXECUTIVE DEVICE
SE1651136A1 (en) * 2016-08-24 2018-02-25 Organoclick Ab Bio-based pec compositions as binders for fiber based materials, textiles, woven and nonwoven materials
LT3538066T (en) * 2016-11-11 2022-04-11 Anteis Sa Hyaluronic acid dermal fillers crosslinked with citric acid, method for making same and uses thereof
US10603070B2 (en) 2016-12-05 2020-03-31 Daniel E. Walzman Alternative use for hydrogel intrasaccular occlusion device with a spring for structural support
US10448970B2 (en) 2016-12-05 2019-10-22 Daniel E. Walzman Alternative use for hydrogel intrasaccular occlusion device with telescoping central support element
AU2018240375C1 (en) 2017-03-22 2024-02-01 Ascendis Pharma A/S Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
RU2019135202A (en) 2017-04-05 2021-05-05 Джелесис ЭлЭлСи IMPROVED SUPERABORATIVE MATERIALS AND METHODS FOR THEIR PRODUCTION
JP2020516629A (en) * 2017-04-14 2020-06-11 ジェレシス,エルエルシー Compositions and methods for treating or preventing intestinal permeability-related disorders
FR3068039B1 (en) 2017-06-22 2020-07-10 Jellynov SELF-FOAMING COMPOSITION IN ACID MEDIUM AND PREPARATION METHOD
GB201711644D0 (en) 2017-07-19 2017-08-30 Satie8 Ltd Polymer Compositions
EP3685876A4 (en) * 2017-09-19 2021-09-08 LG Household & Health Care Ltd. Hyaluronic acid filler using microneedle patch
IT201700105979A1 (en) * 2017-09-21 2019-03-21 Giacomo Guerrini Biodegradable polymer-composite clay - Biodegradable polymer-clay composite
CN108003391A (en) * 2017-12-01 2018-05-08 武汉理工大学 A kind of full polysaccharide derivates base superabsorbent hydrogel and its preparation method and application
DE112017008257A5 (en) 2017-12-07 2020-09-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. PROCESS FOR CROSSLINKING POLYMERS WITH NUCLEOPHILIC FUNCTIONALITIES, CROSSLINKED POLYMERS AND USES THEREOF
CN108354166A (en) * 2018-02-06 2018-08-03 吉林农业大学 A kind of high dietary-fiber cornstarch gel and preparation method thereof
US20210221962A1 (en) * 2018-02-20 2021-07-22 Advanced Aesthetic Technologies, Inc. High concentration hydrogels and related methods
CN110732037B (en) 2018-07-20 2023-05-26 广州倍绣生物技术有限公司 Hemostatic paste and preparation method thereof
CN110064344B (en) * 2018-09-07 2023-03-28 中北大学 Folic acid supramolecular organogel with high thermal stability
FR3089224B1 (en) 2018-12-04 2020-12-11 Jellynov Self-foaming composition in an acid medium and method of preparation
CN112368029A (en) * 2019-02-06 2021-02-12 特清公司 Systems and methods for removing preservatives from ophthalmic formulations containing complexing agents
CN109675096B (en) * 2019-02-21 2021-03-12 武汉纺织大学 Preparation method of chitosan fiber hydrogel dressing
CN111187429B (en) * 2019-06-18 2020-08-14 吾奇生物医疗科技(镇江)有限公司 Double-crosslinking collagen hydrogel material, and preparation method and application thereof
CN110496135B (en) * 2019-09-27 2022-02-01 南京易亨制药有限公司 Composition for losing weight
CN113423386A (en) * 2019-10-01 2021-09-21 美国倍利年制药有限公司 Methods of treating or preventing obesity and weight management
AU2020405238A1 (en) 2019-12-19 2022-07-14 TearClear Corp. Preservative removal from eye drops
CN111218013B (en) * 2020-01-22 2022-08-23 上海应用技术大学 Preparation method and application of crosslinked polymer
RU2743941C1 (en) * 2020-07-29 2021-03-01 Федеральное государственное бюджетное учреждение науки Институт химии Дальневосточного отделения Российской академии наук (ИХ ДВО РАН) Method for producing biopolymeric hydrogel
CN112341672B (en) * 2020-10-22 2022-03-04 爱美客技术发展股份有限公司 Modified cross-linked carboxymethyl cellulose gel and preparation method thereof
CN112262984B (en) * 2020-11-03 2021-12-14 吴良平 Hydrogel for assisting in diet control and preparation method and application thereof
CN112263563A (en) * 2020-11-03 2021-01-26 吴良平 Hydrogel with bowel relaxing function and preparation method and application thereof
CN112876307B (en) * 2021-01-21 2022-09-20 西北师范大学 Degradable super absorbent resin with nitrogen fertilizer slow-release effect and preparation method thereof
CN112915974A (en) * 2021-02-05 2021-06-08 青岛科技大学 Malic acid-chitosan nanopore hydrogel microspheres and preparation method and application thereof
RU2766223C1 (en) * 2021-03-10 2022-02-10 Федеральное государственное бюджетное учреждение науки Институт химии Дальневосточного отделения Российской академии наук (ИХ ДВО РАН) Method for obtaining biopolymer films
CN116003830A (en) * 2021-03-23 2023-04-25 叶绿体(新加坡)有限公司 Superabsorbent hydrogel, preparation method and application thereof
CN113854567A (en) * 2021-09-28 2021-12-31 至睿生物(江苏)有限公司 Edible hydrogel, preparation method and application thereof, and intragastric filler comprising edible hydrogel
CN114381014B (en) * 2021-12-16 2023-02-17 佑道(天津)健康咨询有限公司 Biodegradable hydrogel and application thereof
KR102441137B1 (en) * 2022-02-07 2022-09-06 김환철 A biocompatible polymer hydrogel comprising an ether group capable of controlling the degradation rate
CN114702734A (en) * 2022-04-08 2022-07-05 重庆师范大学 Cellulose ether gel and preparation method and application thereof

Citations (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547571A (en) * 1983-10-06 1985-10-15 Kohjin Co., Ltd. Process for preparing carboxymethyl ethyl cellulose suitable for enteric coating
US4609640A (en) * 1981-11-17 1986-09-02 Toyo Jozo Company, Ltd. Preparation having excellent absorption property
US4697008A (en) * 1985-12-13 1987-09-29 Dai-Ichi Kogyo Seiyaku Co., Ltd. Production of water-insoluble alkali metal salts of carboxyalkyl cellulose
US5047513A (en) * 1986-07-10 1991-09-10 Hoffmann-La Roche Inc. Metal chelate resins
US5137537A (en) * 1989-11-07 1992-08-11 The Procter & Gamble Cellulose Company Absorbent structure containing individualized, polycarboxylic acid crosslinked wood pulp cellulose fibers
US5550189A (en) * 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
US5736595A (en) * 1993-05-03 1998-04-07 Chemische Fabrik Stockhausen Gmbh Polymer composition, absorbent material composition, their production and their use
US6207699B1 (en) * 1999-06-18 2001-03-27 Richard Brian Rothman Pharmaceutical combinations for treating obesity and food craving
US20010002411A1 (en) * 1996-07-11 2001-05-31 Ronan John A. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US6475530B1 (en) * 2000-05-31 2002-11-05 Eric H. Kuhrts Methods and compositions for producing weight loss
US6476006B2 (en) * 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US20030027787A1 (en) * 2000-11-10 2003-02-06 Group Lysac Inc./Lysac Group Inc. Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbant
US20030144642A1 (en) * 1999-09-21 2003-07-31 Weyerhaeuser Company Absorbent composite having fibrous bands
US20030232895A1 (en) * 2002-04-22 2003-12-18 Hossein Omidian Hydrogels having enhanced elasticity and mechanical strength properties
US6765042B1 (en) * 1998-12-16 2004-07-20 Sca Hygiene Products Zeist B.V. Acidic superabsorbent polysaccharides
US20050031680A1 (en) * 2000-11-20 2005-02-10 Jaime Simon In vivo use of water absorbent polymers
US6943211B1 (en) * 1999-02-23 2005-09-13 Life Medical Sciences, Inc. Polymer compounds
US7056957B2 (en) * 2003-04-25 2006-06-06 Kos Pharmaceuticals, Inc. Formation of strong superporous hydrogels
US20060142478A1 (en) * 2004-12-29 2006-06-29 Mengkui Luo Carboxyalkyl cellulose polymer network
US20060142480A1 (en) * 2004-12-29 2006-06-29 Mengkui Luo Method of making carboxyalkyl cellulose polymer network
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US7300965B2 (en) * 2004-12-29 2007-11-27 Weyerhaeuser Company Mixed polymer network
US20080009616A1 (en) * 2004-06-21 2008-01-10 Markus Frank Water-Absorbing Polysaccharide and Method for Producing the Same
US20080075785A1 (en) * 2006-09-22 2008-03-27 San-Laung Chow Controlled release hydrogel formulation
US20080107732A1 (en) * 2004-03-25 2008-05-08 Dharmadhikari Nitin Bhalachand Gastric Retention System
US20080147026A1 (en) * 2006-12-15 2008-06-19 Jian Qin Absorbent fiber with a low absorbent capacity and slow absorption rate
US20080166410A1 (en) * 2001-06-28 2008-07-10 Basf Aktiengesellschaft Acidic Superabsorbent Hydrogels
US20080184939A1 (en) * 2003-07-11 2008-08-07 The Clorox Company Composite Absorbent Particles
US20080241094A1 (en) * 2002-12-19 2008-10-02 Baronova, Inc. Ingestible formulations for transient, noninvasive reduction of gastric volume
US20090099541A1 (en) * 2007-10-15 2009-04-16 Jian Qin Absorbent composites having improved fluid wicking and web integrity
US7541396B2 (en) * 2004-12-29 2009-06-02 Weyerhaeuser Nr Company Method for making carboxyalkyl cellulose
US7612016B2 (en) * 2001-05-25 2009-11-03 Evonik Stockhausen Gmbh Preparation of superabsorbent polymers
US20130089737A1 (en) * 2011-06-07 2013-04-11 Alessandro Sannino Method for producing hydrogels

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526048A (en) * 1967-06-07 1970-09-01 Us Agriculture Cellulose fibers cross-linked and esterified with polycarboxylic acids
US3589364A (en) 1968-03-14 1971-06-29 Buckeye Cellulose Corp Bibulous cellulosic fibers
EP0010519A1 (en) 1978-10-12 1980-04-30 Battelle Memorial Institute Process for cross-linking carboxymethyl cellulose and products obtained by this process
DD212969A1 (en) * 1982-12-30 1984-08-29 Adw Inst Polymerenchemie PROCESS FOR MODIFYING CARBOXYMETHYL CELLULOSE
ZA841044B (en) * 1983-02-17 1984-09-26 Merrell Dow Pharma Dry mix cellulose ether compositions as bulk laxatives
JPH0672106B2 (en) * 1987-04-22 1994-09-14 花王株式会社 Laxative composition
IT1219587B (en) * 1988-05-13 1990-05-18 Fidia Farmaceutici SELF-CROSS-LINKED CARBOXYLY POLYSACCHARIDES
DE3903672C1 (en) * 1989-02-08 1990-02-01 Lohmann Gmbh & Co Kg
US5190563A (en) * 1989-11-07 1993-03-02 The Proctor & Gamble Co. Process for preparing individualized, polycarboxylic acid crosslinked fibers
WO1991016057A1 (en) * 1990-04-18 1991-10-31 University Of Utah COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING
US5207934A (en) * 1991-05-07 1993-05-04 Union Oil Company Of California Crosslinked hydroxyethylcellulose and its uses
US5111886A (en) * 1991-05-07 1992-05-12 Union Oil Company Of California Crosslinked hydroxyethylcellulose and its uses
US5247072A (en) * 1991-10-25 1993-09-21 Kimberly-Clark Corporation Carboxyalkyl polysaccharides having improved absorbent properties and process for the preparation thereof
JP4032261B2 (en) * 1993-05-03 2008-01-16 ストックハウゼン ゲーエムベーハー Polymer composition, absorbent composition, production and use thereof
JP3274550B2 (en) * 1993-08-03 2002-04-15 株式会社日本触媒 Manufacturing method of water absorbing material
ATE173773T1 (en) * 1994-03-18 1998-12-15 Procter & Gamble THE PRODUCTION OF INDIVIDUAL CELLULOSE FIBERS CROSS-LINKED WITH POLYCARBOXYLIC ACID
WO1996002276A2 (en) * 1994-07-18 1996-02-01 Gel Sciences, Inc. Novel polymer gel networks and methods of use
CN1095643C (en) * 1994-12-09 2002-12-11 普罗克特和甘保尔公司 Absorbent composites and absorbent articles containing the same
US20010006677A1 (en) * 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
DE19654745C5 (en) * 1996-12-30 2004-01-22 Lechner, M.D., Prof. Dr. Biodegradable absorbent, its manufacture and use
AU3561697A (en) * 1997-06-24 1999-01-04 Sca Molnlycke Ab Absorbent polymer material based on renewable starting materials
CO5070628A1 (en) * 1997-11-25 2001-08-28 Kimberly Clark Co ABSORBENT FOAM THAT INCLUDES A POLYMER, THE ABSORBENT PRODUCT THAT UNDERSTANDS IT AND THE PROCESS FOR PREPARATION
US5948829A (en) * 1997-11-25 1999-09-07 Kimberly-Clark Worldwide, Inc. Process for preparing an absorbent foam
JP2000060487A (en) * 1998-08-27 2000-02-29 Kao Corp Constipation improver
WO2000032064A1 (en) 1998-11-30 2000-06-08 Hercules Incorporated Controlled release carbohydrate embedded in a crosslinked polysaccharide
US6471824B1 (en) * 1998-12-29 2002-10-29 Weyerhaeuser Company Carboxylated cellulosic fibers
GB9924636D0 (en) 1999-10-18 1999-12-22 Norgine Bv Laxative preparation
EP1134232A1 (en) * 2000-03-16 2001-09-19 SCA Hygiene Products AB Polysaccharide-based superabsorbent film
BR0110918A (en) * 2000-05-15 2004-02-10 Kimberly Clark Co Polysaccharide absorbers and process for providing a water-insoluble and water-insoluble modified polysaccharide that has stable, preferred absorption properties after aging
ATE438418T1 (en) * 2001-05-01 2009-08-15 Av Topchiev Inst Petrochemical HYDROGEL COMPOSITIONS
JP4132993B2 (en) * 2002-06-03 2008-08-13 住友精化株式会社 Water absorbent resin and method for producing the same
US7648619B2 (en) * 2002-06-04 2010-01-19 Industrial Technology Research Hydrogel-driven micropump
JP2006522819A (en) 2003-04-08 2006-10-05 プロジェニックス ファーマシューティカルズ,インコーポレーテッド Combination therapy of constipation combined with laxatives and peripheral opioid antagonists
JP5448297B2 (en) * 2003-10-16 2014-03-19 テクコム・グループ・リミテッド・ライアビリティ・カンパニー Reduced digestible carbohydrate food with reduced blood response
US8128958B2 (en) * 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
US20050143571A1 (en) * 2003-12-30 2005-06-30 Weyerhaeuser Company Method for forming individualized intrafiber crosslinked cellulosic fibers with improved brightness and color
EP1833309A1 (en) * 2004-12-08 2007-09-19 Unilever Plc Satiety enhancing food product and a method for manufacturing such
US20060142561A1 (en) * 2004-12-29 2006-06-29 Mengkui Luo Carboxyalkyl cellulose
ITTO20040918A1 (en) * 2004-12-29 2005-03-29 Luigi Ambrosio POLYMERIC HYDROGEL BIODEGRADABLE ABSORBERS AND PROCEDURE FOR THEIR PREPARATION
FR2882366B1 (en) * 2005-02-18 2008-04-18 Coletica Sa RETICULATED CARBOHYDRATE POLYMER, IN PARTICULAR BASED ON POLYSACCHARIDES AND / OR POLYOLS
RU2008142623A (en) 2006-03-28 2010-05-10 Джелесис, Инк. (Us) METHOD AND MEDICINAL PRODUCT FOR INCREASING HYDROGEL SWELLABILITY AND / OR DURATION OF ITS ACTIVITY IN THE STOMACH OF ANIMAL ORGANISM, METHOD AND MEDICINAL PRODUCT FOR DELIVERY OF MEDICINE
BRPI0709882A2 (en) 2006-03-30 2011-07-26 Gelesis Inc styrene - maleic anhydride copolymers for bioapplications and their preparation
AU2007233106A1 (en) * 2006-03-30 2007-10-11 Exotech Bio Solutions Ltd. Styrene-maleic anhydride copolymers for bioapplications and their preparation
JP2008285611A (en) * 2007-05-18 2008-11-27 Daicel Chem Ind Ltd Process for producing crosslinked gel and its crosslinked gel
WO2009022358A1 (en) * 2007-08-10 2009-02-19 Luigi Ambrosio Superabsorbent polymer hydro gels and a method of preparing thereof
CA2743559C (en) * 2008-11-18 2018-01-02 One S.R.I. Methods and compositions for weight management and for improving glycemic control, comprising cross-linked, edible polymer hydrogels
MX2016016800A (en) * 2014-06-20 2017-05-03 Gelesis Llc Methods for treating overweight or obesity.
JP6847841B2 (en) * 2015-01-29 2021-03-24 ジェレシス,エルエルシー A method for producing a hydrogel having both a high elastic modulus and a high absorbency
RU2745992C2 (en) 2016-04-25 2021-04-05 Джелесис ЭлЭлСи Obstipation treatment method

Patent Citations (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609640A (en) * 1981-11-17 1986-09-02 Toyo Jozo Company, Ltd. Preparation having excellent absorption property
US4547571A (en) * 1983-10-06 1985-10-15 Kohjin Co., Ltd. Process for preparing carboxymethyl ethyl cellulose suitable for enteric coating
US4697008A (en) * 1985-12-13 1987-09-29 Dai-Ichi Kogyo Seiyaku Co., Ltd. Production of water-insoluble alkali metal salts of carboxyalkyl cellulose
US5047513A (en) * 1986-07-10 1991-09-10 Hoffmann-La Roche Inc. Metal chelate resins
US5137537A (en) * 1989-11-07 1992-08-11 The Procter & Gamble Cellulose Company Absorbent structure containing individualized, polycarboxylic acid crosslinked wood pulp cellulose fibers
US5550189A (en) * 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
US5736595A (en) * 1993-05-03 1998-04-07 Chemische Fabrik Stockhausen Gmbh Polymer composition, absorbent material composition, their production and their use
US6387978B2 (en) * 1996-07-11 2002-05-14 Boston Scientific Corporation Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US20010002411A1 (en) * 1996-07-11 2001-05-31 Ronan John A. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US20010038831A1 (en) * 1997-05-13 2001-11-08 Kiham Park Super-absorbent hydrogel foams
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US6765042B1 (en) * 1998-12-16 2004-07-20 Sca Hygiene Products Zeist B.V. Acidic superabsorbent polysaccharides
US20040236016A1 (en) * 1998-12-16 2004-11-25 Thornton Jeffrey Wilson Acidic superabsorbent polysaccharides
US6943211B1 (en) * 1999-02-23 2005-09-13 Life Medical Sciences, Inc. Polymer compounds
US6207699B1 (en) * 1999-06-18 2001-03-27 Richard Brian Rothman Pharmaceutical combinations for treating obesity and food craving
US20030144642A1 (en) * 1999-09-21 2003-07-31 Weyerhaeuser Company Absorbent composite having fibrous bands
US6475530B1 (en) * 2000-05-31 2002-11-05 Eric H. Kuhrts Methods and compositions for producing weight loss
US6476006B2 (en) * 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US20030203878A1 (en) * 2000-06-23 2003-10-30 Moshe Flashner-Barak Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US20030027787A1 (en) * 2000-11-10 2003-02-06 Group Lysac Inc./Lysac Group Inc. Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbant
US20050031680A1 (en) * 2000-11-20 2005-02-10 Jaime Simon In vivo use of water absorbent polymers
US20130195975A1 (en) * 2000-11-20 2013-08-01 Sorbent Therapeutics, Inc. In vivo use of water absorbent polymers
US7612016B2 (en) * 2001-05-25 2009-11-03 Evonik Stockhausen Gmbh Preparation of superabsorbent polymers
US20080166410A1 (en) * 2001-06-28 2008-07-10 Basf Aktiengesellschaft Acidic Superabsorbent Hydrogels
US6960617B2 (en) * 2002-04-22 2005-11-01 Purdue Research Foundation Hydrogels having enhanced elasticity and mechanical strength properties
US20030232895A1 (en) * 2002-04-22 2003-12-18 Hossein Omidian Hydrogels having enhanced elasticity and mechanical strength properties
US20080241094A1 (en) * 2002-12-19 2008-10-02 Baronova, Inc. Ingestible formulations for transient, noninvasive reduction of gastric volume
US7056957B2 (en) * 2003-04-25 2006-06-06 Kos Pharmaceuticals, Inc. Formation of strong superporous hydrogels
US20080184939A1 (en) * 2003-07-11 2008-08-07 The Clorox Company Composite Absorbent Particles
US20080107732A1 (en) * 2004-03-25 2008-05-08 Dharmadhikari Nitin Bhalachand Gastric Retention System
US20080009616A1 (en) * 2004-06-21 2008-01-10 Markus Frank Water-Absorbing Polysaccharide and Method for Producing the Same
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US20060142480A1 (en) * 2004-12-29 2006-06-29 Mengkui Luo Method of making carboxyalkyl cellulose polymer network
US7541396B2 (en) * 2004-12-29 2009-06-02 Weyerhaeuser Nr Company Method for making carboxyalkyl cellulose
US7300965B2 (en) * 2004-12-29 2007-11-27 Weyerhaeuser Company Mixed polymer network
US20060142478A1 (en) * 2004-12-29 2006-06-29 Mengkui Luo Carboxyalkyl cellulose polymer network
US20080075785A1 (en) * 2006-09-22 2008-03-27 San-Laung Chow Controlled release hydrogel formulation
US20080147026A1 (en) * 2006-12-15 2008-06-19 Jian Qin Absorbent fiber with a low absorbent capacity and slow absorption rate
US20090099541A1 (en) * 2007-10-15 2009-04-16 Jian Qin Absorbent composites having improved fluid wicking and web integrity
US20130089737A1 (en) * 2011-06-07 2013-04-11 Alessandro Sannino Method for producing hydrogels

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11130823B2 (en) 2011-06-07 2021-09-28 Gelesis Llc Method for producing hydrogels
US9353191B2 (en) 2011-06-07 2016-05-31 Gelesis Llc Method for producing hydrogels
US9855294B2 (en) 2014-06-20 2018-01-02 Gelesis, Llc Methods for treating overweight or obesity
US11628184B2 (en) 2014-06-20 2023-04-18 Gelesis, Llc Methods for treating overweight or obesity
US10584183B2 (en) 2015-01-29 2020-03-10 Gelesis, Llc Method for producing hydrogels coupling high elastic modulus and absorbance
US10179824B2 (en) 2015-01-29 2019-01-15 Gelesis Llc Method for producing hydrogels coupling high elastic modulus and absorbance
US11130824B2 (en) 2015-01-29 2021-09-28 Gelesis Llc Method for producing hydrogels coupling high elastic modulus and absorbance
US11517014B2 (en) 2015-05-18 2022-12-06 Zymtronix, Inc. Magnetically immobilized microbiocidal enzymes
US10881102B2 (en) 2015-05-18 2021-01-05 Zymtronix, Llc Magnetically immobilized microbiocidal enzymes
US10792649B2 (en) 2015-07-15 2020-10-06 Zymtronix, Llc Automated bionanocatalyst production
WO2017136745A1 (en) 2016-02-05 2017-08-10 Entrega Inc. Oral dosage form with drying agent for delivery of active agent
WO2017180383A1 (en) * 2016-04-16 2017-10-19 Zymtronix, Llc Magnetic macroporous polymeric hybrid scaffolds for immobilizing bionanocatalysts
JP2019515922A (en) * 2016-04-25 2019-06-13 ジェレシス,エルエルシー How to treat constipation
JP7132128B2 (en) 2016-04-25 2022-09-06 ジェレシス,エルエルシー How to treat constipation
AU2017257494B2 (en) * 2016-04-25 2022-12-01 Gelesis, Llc. Method for treating constipation
US10098907B2 (en) 2016-04-25 2018-10-16 Gelesis Llc Method for treating constipation
WO2017189422A1 (en) * 2016-04-25 2017-11-02 Gelesis, Llc. Method for treating constipation
RU2745992C2 (en) * 2016-04-25 2021-04-05 Джелесис ЭлЭлСи Obstipation treatment method
US10993436B2 (en) 2016-08-13 2021-05-04 Zymtronix Catalytic Systems, Inc. Magnetically immobilized biocidal enzymes and biocidal chemicals
EP3517116A4 (en) * 2016-09-23 2019-10-23 Sullivan Barrera, Michael O., Jr. A cross-linked structure for tissue regeneration and engineering and the method for synthesising same
GB2579300A (en) * 2017-07-28 2020-06-17 Kimberly Clark Co Nanoporous superabsorbent particles
WO2019023060A3 (en) * 2017-07-28 2019-03-07 Kimberly-Clark Worldwide, Inc. Nanoporous superabsorbent particles
AU2018307477B2 (en) * 2017-07-28 2022-12-22 Kimberly-Clark Worldwide, Inc. Nanoporous superabsorbent particles
GB2579300B (en) * 2017-07-28 2022-10-05 Kimberly Clark Co Nanoporous superabsorbent particles
KR20210013644A (en) * 2018-06-27 2021-02-04 킴벌리-클라크 월드와이드, 인크. Absorbent article containing nanoporous superabsorbent particles
KR20210006014A (en) * 2018-06-27 2021-01-15 킴벌리-클라크 월드와이드, 인크. Nanoporous superabsorbent particles
GB2588553A (en) * 2018-06-27 2021-04-28 Kimberly Clark Co Nanoporous Superabsorbent Particles
KR102296450B1 (en) 2018-06-27 2021-09-02 킴벌리-클라크 월드와이드, 인크. Absorbent Article Containing Nanopore Superabsorbent Particles
GB2588553B (en) * 2018-06-27 2022-10-19 Kimberly Clark Co Nanoporous Superabsorbent Particles
GB2589785B (en) * 2018-06-27 2022-10-19 Kimberly Clark Co Absorbent article containing nanoporous superabsorbent particles
WO2020005230A1 (en) * 2018-06-27 2020-01-02 Kimberly-Clark Worldwide, Inc. Absorbent article containing nanoporous superabsorbent particles
WO2020005229A1 (en) * 2018-06-27 2020-01-02 Kimberly-Clark Worldwide, Inc. Nanoporous superabsorbent particles
KR102294696B1 (en) * 2018-06-27 2021-08-30 킴벌리-클라크 월드와이드, 인크. Nanopore Superabsorbent Particles
US11596924B2 (en) * 2018-06-27 2023-03-07 Kimberly-Clark Worldwide, Inc. Nanoporous superabsorbent particles
GB2589785A (en) * 2018-06-27 2021-06-09 Kimberly Clark Co Absorbent article containing nanoporous superabsorbent particles
US11931469B2 (en) 2018-07-20 2024-03-19 Kimberly-Clark Worldwide, Inc. Absorbent article having a reduced humidity level
US11931468B2 (en) 2018-07-20 2024-03-19 Kimberly-Clark Worldwide, Inc. Feminine care absorbent article containing nanoporous superabsorbent particles

Also Published As

Publication number Publication date
SI2532685T1 (en) 2015-04-30
RU2641749C2 (en) 2018-01-22
JP2015212388A (en) 2015-11-26
US8658147B2 (en) 2014-02-25
JP2020097741A (en) 2020-06-25
RU2493170C2 (en) 2013-09-20
RU2010105385A (en) 2011-09-20
DK2463308T3 (en) 2015-02-09
PL2463308T3 (en) 2015-04-30
SI2463308T1 (en) 2015-04-30
US20200046755A1 (en) 2020-02-13
WO2009021701A2 (en) 2009-02-19
WO2009022358A1 (en) 2009-02-19
JP7027083B2 (en) 2022-03-01
EP2514444A1 (en) 2012-10-24
JP2010535911A (en) 2010-11-25
PT2463308E (en) 2015-02-10
CA2695974C (en) 2016-10-18
JP2014065717A (en) 2014-04-17
CY1115980T1 (en) 2017-01-25
EP2463308B1 (en) 2014-12-03
HUE024121T2 (en) 2016-02-29
AU2008286354B2 (en) 2014-05-29
US20100234233A1 (en) 2010-09-16
CN101796075B (en) 2014-05-07
EP2178922A2 (en) 2010-04-28
DK2532685T3 (en) 2015-02-16
HUE024123T2 (en) 2016-02-29
EP2532685A1 (en) 2012-12-12
CN101796075A (en) 2010-08-04
US10086014B2 (en) 2018-10-02
HK1172633A1 (en) 2013-04-26
EP2532685B1 (en) 2014-12-03
WO2009021701A3 (en) 2009-05-07
PT2532685E (en) 2015-02-10
CN104327191A (en) 2015-02-04
ES2526905T3 (en) 2015-01-16
ES2554163T3 (en) 2015-12-16
MX2010001629A (en) 2010-08-09
PL2532685T3 (en) 2015-05-29
RU2013126920A (en) 2014-12-20
CY1115978T1 (en) 2017-01-25
ES2526788T3 (en) 2015-01-15
AU2008286354A1 (en) 2009-02-19
HRP20150121T1 (en) 2015-05-22
EP2535359A1 (en) 2012-12-19
CA2695974A1 (en) 2009-02-19
EP2178922B1 (en) 2015-10-07
JP5760069B2 (en) 2015-08-05
JP2018040002A (en) 2018-03-15
JP5485151B2 (en) 2014-05-07
US20160361350A1 (en) 2016-12-15
US20210353665A1 (en) 2021-11-18
EP2463308A1 (en) 2012-06-13

Similar Documents

Publication Publication Date Title
US20210353665A1 (en) Polymer Hydrogels and Methods of Preparation Thereof
US11130823B2 (en) Method for producing hydrogels
AU2016219713B2 (en) Polymer hydrogels and methods of preparation thereof
AU2013204055C1 (en) Polymer hydrogels and methods of preparation thereof

Legal Events

Date Code Title Description
STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION